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ABSTRACT  
 
Baig, Tayyba, Ph.D., Fall 2008      Integrative Microbiology and Biochemistry 
  
Abstract Title: Studies of the dimerization and packaging signals in HIV-2 RNA 
 
Chairperson: Dr. J. Stephen Lodmell  
 
Co-Chairperson:  Dr. Jean-Marc Lanchy  
 
 
  The investigation of sequences and structures in the 5’ untranslated leader region 
(5’UTR) of HIV genomic RNA is essential for understanding viral replication because 
the 5’UTR regulates several essential functions by the alternate presentation and 
sequestration of signals through conformational changes. Our main focus in this study 
was to understand those sequences and structures that are involved in dimerization and 
packaging of HIV-2 RNA. Progressing from previous findings, we studied in detail a 10-
nucleotide palindrome sequence (pal; 5’-GGAGUGCUCC-3’) of the 5’UTR, located 
within the major packaging signal, upstream of the dimerization signal (SL1: stem loop-
1). Pal has been shown to interact intramolecularly with SL1 to inhibit SL1-mediated 
HIV-2 leader RNA dimerization in vitro. We carried out three lines of experiments in an 
effort to understand the roles of pal in viral RNA dimerization and packaging.  
  The first study was achieved through randomization of pal and the subsequent selection 
from a population of random-pal RNAs those with enhanced or diminished dimerization 
properties in vitro. We showed that the 3’-pal motif (3’-pal; GCUCC-3’) is involved in 
intramolecular interactions with a sequence downstream of SL1 that regulates SL1-
mediated HIV-2 leader RNA dimerization. The second study was designed to investigate 
the role of 5’-pal motif (5’-GGAGU) in RNA packaging in vivo. Our findings indicated 
that the 5’-pal is essential for viral replication and genomic RNA packaging. Based on 
these findings, we proposed that 5’-pal is a binding element for the packaging proteins. 
Therefore, a third study was designed in which HIV-2 packaging proteins (Gag and NC) 
were expressed, purified, and assayed for binding with wild-type and mutant 5’-pal 
RNAs in vitro. These results suggested that the 5’-pal is a binding element for Gag 
protein. In summary, we have showed that pal is an important regulator of dimerization 
and packaging processes of HIV-2 RNA. We also demonstrated that pal is composed of 
two motifs with distinct functions. Overall, our study significantly contributes to the 
understanding of HIV-2 RNA dimerization and packaging, which may ultimately lead to 
the identification of novel antiretroviral targets.  
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  Chapter 1: Introduction 
 
1.1. AIDS/HIV/Dimerization and packaging 
of HIV RNA 
 
Since the discovery of AIDS, HIV infection has been diagnosed nearly all over 
the world, making AIDS one of the most devastating diseases in human history and has 
killed millions of people. In developed nations, AIDS is a controllable disease due to the 
accessibility of anti-HIV therapy, which inhibits viral replication by attacking key steps 
of the viral replication cycle thereby reducing viremia. The development of anti-HIV 
therapy became possible by obtaining a detailed understanding of essential steps of the 
HIV-1 replication cycle. However, the same essential steps of a second AIDS causing 
virus, HIV-2, have been less well studied and more research is warranted. Therefore, the 
impetus of the research presented in this dissertation was to understand in detail two 
crucial steps, RNA dimerization and packaging, of the HIV-2 replication cycle.  
1.1.1. AIDS (acquired immunodeficiency 
syndrome) 
 
In June 1981, the Morbidity and Mortality Weekly reported that an unusual form 
of Pneumocystis carinii pneumonia (PCP) causing immunosuppressive disease had been 
diagnosed among homosexual men living in Los Angeles, USA (Weekly, 1981). Further, 
the diagnosis of PCP with immunosuppressive disease in groups other than homosexuals 
at other places (Masur et al, 1981) announced the beginning of an epidemic that lead to a 
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major worldwide health dilemma (see review; Fauci, 2006). Because this disease is not 
genetically inherited and it suppresses the immune system, it was named AIDS (acquired 
immunodeficiency syndrome) (Marx, 1982). 
The cause of AIDS was identified in 1983 in the lab of Dr. Luc Montagnier, who 
reported an association between the development of AIDS with the infection of a 
retrovirus (Barre-Sinoussi et al, 1983). The name of this AIDS retrovirus was given in 
1986 as the HIV-1 (human immunodeficiency virus type 1) (Coffin et al, 1986). About 
that time, a second AIDS causing virus was isolated from West African patients and was 
called HIV-2 (human immunodeficiency virus type 2) (Clavel et al, 1986a). According to 
one estimate, over 50 million people have been infected with HIV. Of those, 33 million 
people are living and 25 million have died (see reviews; Fauci, 2006; Ho & Bieniasz, 
2008).  
 
1.1.2. HIV (human immunodeficiency virus) 
1.1.2.1. HIV is a retrovirus 
 
The Retroviridae comprise a family of RNA viruses whose genetic material is 
converted into double stranded proviral DNA in the host cell with the help of  RT 
(reverse transcriptase) in a process called reverse transcription (Baltimore, 1970; Temin 
& Mizutani, 1970). Within the Retroviridae is a virus group called the lentiviruses (lenti 
is the Greek root for slow), which are characterized by producing slow progressing 
disease. Many of these viruses affect the cells of the immune system in animals and 
humans (see reviews; Shuljak, 2006; Sigurdsson, 1954). The detection of reverse 
 3 
transcriptase activity in the cultured lymphocytes, obtained from AIDS patients revealed 
that the virus, which destroys the human immune system, is a retrovirus (Barre-Sinoussi 
et al, 1983). Due to the structural and sequential alignment with other lentiviruses, HIV 
was recognized as a lentivirus (Barre-Sinoussi et al, 1983; Gonda et al, 1985; Munn et al, 
1985). 
 
1.1.2.2. Origin and epidemiology of HIV 
 
The origin of HIV became clearer with the finding of an evolutionary link 
between HIV and related retroviruses from African nonhuman primates called SIVs 
(simian immunodeficiency viruses) (see review; Hahn et al, 2000). HIV-1 seems to have 
been passed on to humans from SIVcpz (chimpanzee) (Gao et al, 1999). The HIV-1 
strains present in infected human populations are classified into three groups. The first 
group is called the ‘main group’, group M, and this group is the major cause of infections 
in the world. The second group consists of highly divergent strains and is called the 
‘outlier group’, group O, and the third group is called the ‘non-M, non-O group’, group 
N, and a small number of viruses belong to this group (se review; Sharp et al, 2001).  
HIV-2 is closely related to the SIVs that exist in certain monkey populations. The 
HIV-2 seems to have been passed on to humans from SIVsmm (sooty mangabeys) (Chen 
et al, 1997; Gao et al, 1992). Phylogenetic analysis reveals that there are seven subtypes 
(A-G) of HIV-2, of which C, D, E, F, and G are rare. The subtype A is the major case of 
HIV-2 infections and is prevalent in Guinea-Bissau. Subtype B originated in West Africa 
and is occasionally found in Europe. Although HIV-2 has been mostly confined to West 
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Africa, the number of HIV-2 infections is increasing at a high rate in some other regions 
of the world including India and Europe (see review; Reeves & Doms, 2002).  
1.1.2.3. Structure of HIV  
 
           The formation of HIV particles is started by the assembly of the Gag polyprotein 
into a shell beneath the membrane of the budding virions. After assembly and budding, 
the Gag polyprotein is processed into individual structural proteins, the MA (matrix), CA 
(capsid), p2, NC (nucleocapsid), p1 and p6 proteins by viral PR (protease). This 
processing converts the immature particles to mature infectious particles (Ganser-
Pornillos et al, 2008; Henderson et al, 1992; Hoglund et al, 1992). The sizes of mature 
infectious particles range from 120-200 nm (average; ~145 nm) (Briggs et al, 2003) 
(Figure 1). Each particle contains an envelope with ~14 protruding spikes, corresponding 
to envelope glycoproteins (Zhu et al, 2006), the gp120 (glycoprotein 120) and gp41 
(glycoprotein 41). These proteins are external and trans to the membrane respectively 
(Allan et al, 1985; Veronese et al, 1985). The viral envelope encircles the MA protein 
that lines the membrane and the core, which is present in the middle of the particle. The 
core is cone shaped and is composed of CA protein and NC-RNA complex (Briggs et al, 
2003; Ganser et al, 1999; Gelderblom et al, 1987; Hoglund et al, 1992). The RNA is not a 
single molecule, two molecules exist within each particle (see reviews; Greatorex & 
Lever, 1998; Paillart et al, 2004b; Russell et al, 2004). 
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Figure 1. HIV mature virion particle.  
 
 
1.1.2.4. Genome organization of HIV 
 
The HIV RNA genome is capped and polyadenylated (Figure 2B). It is 
approximately 9.2 kb in length and encodes 15 different proteins (Frankel & Young, 
1998; Wain-Hobson et al, 1985). Like other retroviruses, HIV genome contains three 
open reading frames: gag, pol and env (Ratner et al, 1985; Wain-Hobson et al, 1985) 
(Figure 2A).  
The gag encodes the Gag (group specific antigen) precursor polyprotein, which is 
a structural protein and as described above, is cleaved by viral protease during maturation 
of virion particles yielding six proteins (MA, CA, p2, NC, p1 and p6) (Henderson et al, 
1992). The functional roles of these proteins has been described in detail (see review; 
Frankel & Young, 1998), however, a few of those are illustrated here. The MA is 
involved in the stable association of Env glycoproteins to the viral particles (Dorfman et 
al, 1994). The NC binds with the full-length genomic RNA to package them into 
assembling virions (Aldovini & Young, 1990) and as described above, the CA makes the 
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shell of the central core (Ganser et al, 1999; Gelderblom et al, 1987). The p1 and p2 
domains are required for the regulation of proteolytic cleavage of Gag for the production 
of mature infectious virions (Pettit et al, 1994; Wiegers et al, 1998).  The p6 domain of 
Gag is also required for the production of infectious virions (Huang et al, 1995) as well as 
for the incorporation of an accessory protein, Vpr into viral particles during assembly 
process (Kondo & Gottlinger, 1996).  
The pol encodes three enzymes, PR (protease), RT (reverse transcriptase) and IN 
(integrase), which are located at 5’, middle and 3’ sides of pol respectively (Muesing et 
al, 1985; Ratner et al, 1985). The PR performs autoprocessing and processing of 
polyproteins to yield the individual proteins (Debouck et al, 1987; Farmerie et al, 1987; 
Kramer et al, 1986). The RT is involved in retroviral specific reverse transcriptase 
(polymerase and RNase H) activity for conversion of RNA to DNA (di Marzo Veronese 
et al, 1986; Mizrahi et al, 1989) and the IN is involved in the integration process of HIV 
DNA (Bushman et al, 1990; Miller et al, 1997). 
The env encodes the envelope precursor polyprotein that is cleaved into 2 
subunits. One is external to the membrane called gp120 and the other is membrane 
associated called gp41 (Allan et al, 1985; Veronese et al, 1985; Willey et al, 1988). The 
gp120 mediates the binding of HIV virions to CD4 receptor (McDougal et al, 1986) and 
gp41 is responsible for the fusion between viral and cell membranes (Kowalski et al, 
1987).  
In addition to gag, pol and env, HIV contains an array of regulatory and accessory 
genes. These include two regulatory (tat, rev) and four accessory (vif, vpr, vpu and nef) 
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genes (see reviews; Cullen & Greene, 1990; Pavlakis & Felber, 1990) (Figure 2A). The 
tat encodes Tat (transcriptional activator) that is important for replication by mediating 
transactivation of transcription and regulation of gene expression. Tat performs these 
functions by binding to a structured region in RNA called TAR (transactive responsive) 
element (Dayton et al, 1986; Fisher et al, 1986; Garcia et al, 1989; Jakobovits et al, 
1988). The rev encodes Rev (regulator of viral gene expression), which functions as a 
nuclear exporter to export viral RNA into the cytoplasm (Meyer & Malim, 1994).   
The accessory (vif, vpr, vpu and nef) genes encode Vif (viral infectivity factor), 
Vpr (viral protein R), Vpu (viral protein U) and Nef (negative effector) proteins, which 
perform important functions during viral replication (see review; Frankel & Young, 
1998). The Vif is involved in the import of pre-integration complex into the nucleus (see 
review; Frankel & Young, 1998) and is essential for the production of infectious virions 
by inhibiting the antiviral activity of a host factor, APOBEC3 (Mehle et al, 2004; Strebel 
et al, 1987). The Nef and Vpu are involved in the degradation of CD4 cells (Mangasarian 
& Trono, 1997; Tiganos et al, 1997; Willey et al, 1992).    
The gag, pol, env, regulatory and accessory genes are flanked by R (repeat)-U5 
(unique 5’) regions at 5’ UTR (untranslated leader region) and U3 (unique 3’)-R regions 
at 3’UTR of genomic RNA respectively (Figure 2B). These regions are duplicated during 
reverse transcription and form U3-R-U5, termed the LTR (long terminal repeat) region at 
both 5’ and 3’ ends of proviral DNA (Starcich et al, 1985) (Figure 2A).  
The HIV-1 5’UTR contains several conserved sequence and/or structure elements 
including TAR, poly A signal, PBS (primer binding site), SLI (stem loop-1; dimerization 
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signal), SD (splice donor site) and PSI (packaging signal) (Figure 3A). These elements 
are involved in the regulation of many essential steps of the viral replication cycle 
including transcription, polyadenylation, genomic RNA dimerization, reverse 
transcription, splicing, packaging and translation (Berkhout, 1996). 
HIV-1 and HIV-2 viruses are less than 50% alike at the sequence level but contain 
a significant similarity at the genome organization level (Clavel et al, 1986b; Zagury et 
al, 1988). As in HIV-1, the HIV-2 genome also contains a 5’ UTR, consisting of 
conserved structural elements (Figure 3B), important for several functions of the viral 
replication cycle (Berkhout, 1996).  
         
         
        
Figure 2. Organization of the HIV genome. 
A. HIV proviral DNA. The arrow indicates the initiation site of transcription. (Top) Open reading frames 
for HIV structural, regulatory and accessory proteins. B. HIV RNA genome. C. The UTR (untranslated 
leader region) at the 5’ end of RNA genome. 
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Figure 3. Model of the 5’ UTR. 
A. A model of the 5’ UTR of HIV-1 RNA. B. A model of the 5’ UTR of HIV-2 RNA. The structure motifs 
are represented by their putative functions on top and they include TAR (transactivation region), poly A 
(polyadenylation) signal, PBS (primer binding site), SL1 (stem-loop1; dimerization signal), SD (splice 
donor site) Ψ-core (core packaging signal), and AUG (gag initiation codon). C. The dimerization and the 
packaging signals of HIV-2 RNA, which are the focus of study in this dissertation are shown.  
 
B 
C 
Core packaging 
signal (Ψ) 
A 
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1.1.2.5. Replication cycle of HIV 
 
HIV infects the CD4 lymphocytes of immune system and develops cytopathic 
effects resulting in the impairment of immunity (Bowen et al, 1985; Klatzmann et al, 
1984) with subsequent vulnerability to opportunistic infections (Gottlieb et al, 1981). The 
infection starts with the binding of HIV virions to the cell surface. This binding is 
mediated by the interactions between envelope glycoprotein (gp120) of HIV and the 
cellular receptor CD4 along with coreceptors, CCR5 or CXCR4 (Choe et al, 1996; Deng 
et al, 1996; Doranz et al, 1996; Dragic et al, 1996; McDougal et al, 1986). Subsequently, 
viral and cellular membranes fuse (Kowalski et al, 1987) and the viral core is introduced 
into the cell followed by reverse transcription of the viral RNA genome to double 
stranded proviral DNA (see review; Harrich & Hooker, 2002). The proviral DNA is 
directed towards the nucleus with the aid of viral and host proteins and integrated into the 
host genomic DNA with the help of the integrase enzyme (Bukrinsky et al, 1993; Farnet 
& Bushman, 1997). Inside the nucleus, transcription factors bind the 5’ LTR, which 
promotes the transcription of the proviral DNA (Garcia et al, 1989; Kao et al, 1987). The 
resulting viral RNAs are exported into the cytoplasm for the synthesis of viral proteins 
(Feinberg et al, 1986; Pollard & Malim, 1998). As described above, proteins are 
transported towards the cell membrane where they are assembled into viral particles, 
along with two molecules of full-length genomic RNA (Ganser-Pornillos et al, 2008).  
The assembled particles are released (budded) from the plasma membrane of the infected 
cell as immature particles and the viral protease becomes active to cleave the Gag and 
Gag-Pol polyproteins into individual proteins. The cleavage leads to the maturation of the 
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immature particles into infectious virions to infect other cells (Kaplan et al, 1994; Kohl et 
al, 1988; Peng et al, 1989) (Figure 4). 
                                            
Figure 4. A schematic of the HIV replication cycle.  
 
1.1.3. Genomic RNA dimerization of HIV  
 
The genome inside a single HIV-1 particle is a dimer consisting of two identical 
copies of positive stranded RNA molecules joined through non-covalent interactions. (see 
reviews; Greatorex & Lever, 1998; Paillart et al, 2004b; Russell et al, 2004). The dimeric 
nature of HIV-1 genomic RNA was demonstrated by isolating the virion RNAs and 
analyzing them by non-denaturing gel electrophoresis. The analysis showed two RNA 
species: one corresponded to the single RNA molecule called monomer and the other to 
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two RNA molecules called dimer (Fu et al, 1994). Moreover, using EM (electron 
microscopy), the strongest RNA-RNA base-pairing interactions in the dimer of HIV-1 
have been localized to the 5’ end of the genome called the DLS (dimer linkage structure) 
(Hoglund et al, 1997).  
1.1.3.1. Identification of contact sites in DLS 
 
The DLS recognized by EM studies for HIV-1 genomic RNA as described above 
was originally identified in 1990, when Darlix and coworkers showed that in vitro 
transcribed HIV-1 RNAs corresponding to the 5’ UTR of genomic RNA can dimerize in 
vitro even in the absence of proteins (Darlix et al, 1990). Subsequently, the first RNA-
RNA contact sites in this DLS, involved in HIV-1 RNA dimerization were identified in 
HIV-1Mal isolate by using short RNA constructs containing 5’UTR. This site is located 
between the PBS and the SD and was called the DIS or dimerization initiation site 
(Paillart et al, 1994; Skripkin et al, 1994). About the same time, a homologous DIS was 
found for another isolate, HIV-1Lai (Laughrea & Jette, 1994; Muriaux et al, 1995). 
Because the DIS can fold into a hairpin structure, it was called stem-loop 1 (SL1; 
(McBride & Panganiban, 1996)) (Figure 3). 
 
1.1.3.2. Model for SL1-mediated RNA dimerization 
 
HIV-1 SL1 contains an autocomplementary sequence of 6-nts in its apical loop 
(5’-GCGCGC-3’ or 5’-GUGCAC-3’ depending on the isolate). Due to the presence of 
this autocomplementary sequence, it was suggested that dimerization between two RNA 
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molecules is initiated through SL1 loop-loop Watson-Crick base-pairing interaction. This 
model of dimerization initiation was called the kissing loop model (Laughrea & Jette, 
1994; Paillart et al, 1994; Skripkin et al, 1994) (Figure 5A). The kissing complex may 
proceed further through an extended intermolecular interaction to form a stable extended 
duplex, at least when short RNA constructs are used (Greatorex & Lever, 1998; Laughrea 
& Jette, 1996; Muriaux et al, 1996b) (Figure 5A). 
A similar autocomplementary sequence (5’-GGUACC-3’) has been identified in 
the HIV-2 5’ UTR (Dirac et al, 2001; Jossinet et al, 2001; Lanchy & Lodmell, 2002) and 
is located as a homologous SL1 structure (Berkhout, 1996). Using phylogenetic analysis 
of HIV-1 and HIV-2 strains, the HIV-2 DIS has been found to be a conserved structure 
(Berkhout & van Wamel, 1996) that may promote dimerization through similar kissing 
loop and extended duplex formation (Figure 5B). 
 
 
 
Figure 5. The SL1-mediated dimerization model. 
A. The SL1-mediated dimerization model for HIV-1. B. The SL1-mediated dimerization model for HIV-2. 
The dimerization can be initiated by Watson-Crick base-pairing interactions between autocomplementary 
sequences of the loops between two HIV RNA molecules that can proceed through extended intermolecular 
interaction to make extended duplex. 
 
 
 
 
 
A B 
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1.1.3.3. Regulation of RNA dimerization 
 
HIV-1 RNA dimerization has been found to be regulated in vitro by masking of 
SL1 through base-pairing interactions that silences its ability to initiate dimerization 
(Berkhout & van Wamel, 2000). SL1 is located in the 5’ region of genomic RNA, which 
has the capability to adopt alternative conformations. Through structural rearrangements, 
the functional sequences within 5’UTR are either sequestered to silence a function or are 
accessible to perform a function (Abbink & Berkhout, 2003; Lanchy et al, 2003a). The in 
vitro studies have indicated that the 5’UTR of HIV-1 may exist in two mutually exclusive 
conformations called LDI (long distance interactions) or BMH (branched multiple 
hairpins). The SL1 is available to dimerize when the 5’UTR is in the BMH form because 
of the accessibility of autocomplementary sequence, and is unavailable to dimerize when 
the 5’UTR is in the LDI form because of its entrapment through intramolecular 
interactions with the other regions (Abbink & Berkhout, 2003).  
The in vitro characterization of the dimerization properties of longer HIV-2 RNA 
constructs suggested that the HIV-2 5’UTR can also adopt different conformations and 
that sequences located downstream and upstream of SL1 influence SL1-mediated 
dimerization in these RNAs (Dirac et al, 2002a). Further characterization in our 
laboratory mapped these sequences by using the 5’ and 3’ truncated HIV-2 leader RNA 
constructs. These sequences were localized to nucleotides 189-196 and nucleotides 543-
550 of the 5’UTR and were referred to as the C-box and G-box regions. In that study, it 
was proposed that intramolecular LDI between C-box and G-box prevents the use of SL1 
as a dimer element by promoting the sequestration of SL1 in a stable SDI (short-distance 
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intramolecular interaction) (Lanchy et al, 2003b).  
A sequence located just upstream of SL1 was identified through experiments 
utilizing mutagenesis and complementary DNA oligonucleotides as likely the 
sequestration element for SL1 (Lanchy et al, 2003a). This sequence is a palindromic 
element (pal; 5’-GGAGUGCUCC-3’) located upstream of SL1 within the core packaging 
signal and was proposed to be a dimerization regulatory element.  
 
1.1.4. Genomic RNA packaging of HIV 
 
Inside the cytoplasm of an infected cell, there is a vast sea of cellular, spliced and 
unspliced RNAs. During assembly of virion particles in an infected cell, two molecules 
of full-length (unspliced) genomic RNAs are selected and transported into budding virion 
particles in a process called encapsidation or packaging (Figure 6). The primary 
determinants of genome packaging are RNA sequences or structures located towards the 
5’ end of genomic RNA called PSI; ψ (packaging signals) and the NC domain of the 
packaging protein, Gag (see review; D'Souza & Summers, 2005). 
 
 
 
 
           Figure 6. Schematic presentation of the packaging process. 
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Two molecules of full-length genomic RNA molecules are selected and transported into budding virion 
particles with the aid of Gag protein. 
 
As described previously, the HIV-1 Gag polyprotein is a precursor protein in 
immature viral particles and is cleaved into individual proteins by the viral protease. NC 
is one of the proteolytic products of Gag (Henderson et al, 1992)and studies have shown 
that the NC domain, as a part of Gag polyprotein, is critical for genome recognition and 
packaging. Packaging is a selective process because the NC domain recognizes and 
captures mainly viral RNAs that have appropriate signals for packaging. It also 
discriminates between unspliced viral RNAs over spliced viral RNAs for this process (see 
review; D'Souza & Summers, 2005). 
In the initial studies that aimed to find the packaging signals required for efficient 
HIV-1 genomic packaging, it was reported that those signals are located in the 5’ UTR 
between the major SD site and the gag (Aldovini & Young, 1990; Lever et al, 1989; 
McBride & Panganiban, 1997). Following those studies, other elements of the 5’UTR, 
including nucleotides of U5, PBS, TAR and nucleotides within the gag, were also found 
to be important for HIV-1 genome packaging (Clever et al, 2002; D'Souza & Summers, 
2005; Helga-Maria et al, 1999; Luban & Goff, 1994).  
For HIV-2, the packaging sequences that mediate genomic RNA packaging into 
virion particles have also been localized to the 5’UTR. However, there is not universal 
agreement concerning the exact location of these sequences. In some studies, it has been 
shown that, like HIV-1, the nucleotides located between the SD site and gag are essential 
for HIV-2 genome packaging (Arya et al, 1998; Poeschla et al, 1998). Other studies 
indicated that another sequence is crucial for packaging and is located upstream of the SD 
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site. This sequence was called the Ψ-core (core packaging signal) because of its profound 
effects on HIV-2 packaging in vivo (Griffin et al, 2001; Kaye & Lever, 1999; McCann & 
Lever, 1997). In refinement of this work, a 10-nt palindromic sequence located within 
this signal was defined as a critical element for HIV-2 genomic RNA packaging in vivo 
(Lanchy & Lodmell, 2007).  
In vitro binding studies between purified Gag and NC proteins of HIV-1 and in 
vitro synthesized RNA fragments corresponding to 5’ end of HIV-1 genomic RNA have 
been useful in dissecting the packaging mechanism. These studies were helpful to 
identify sequences or structures at the 5’ end of HIV-1 genomic RNA that act as binding 
sites for Gag and NC (Berkowitz et al, 1993; Sakaguchi et al, 1993). Based on these 
studies along with other additional studies, it was reported that the Ψ-site of HIV-1 RNA 
is composed of four stem-loops (SL1-SL4) (Clever et al, 1995). 
For HIV-2, the interactions between packaging proteins and the RNA fragments 
corresponding to the 5’ side of HIV-2 genomic RNA have also been investigated by in 
vitro binding studies. However, there is a limited number of studies and either small HIV-
2 RNAs were used for binding with HIV-2 proteins or large HIV-2 RNAs were used with 
HIV-1 proteins. (Damgaard et al, 1998; Tsukahara et al, 1996). To more accurately 
identify the specific HIV-2 RNA-protein binding sites, it will be necessary to conduct 
binding studies on large HIV-2 RNA transcripts encompassing the entire 5’ UTR with 
either HIV-2 Gag or NC proteins.  
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1.2. Investigation of the structural 
presentation of dimerization and packaging 
signals in 5’UTR 
 
As described above, the 5’ UTR is a conserved and essential region of HIV 
genomic RNA. It contains several sequence or structural signals that are important for 
various steps of viral replication, including RNA dimerization and packaging. The 
appropriate presentation of the RNA dimerization and packaging signals is important for 
temporal regulation of these processes. It has been proposed that the 5’UTR can adopt 
alternate conformations to expose or hide these signals. To investigate this notion, it is 
important to determine which specific RNA structures are essential for the regulation of 
the dimerization and packaging processes.  
 
1.2.1. Combinatorial approaches for 
determining essential RNA structures 
   
 A straightforward way to determine whether a sequence or structure motif is 
essential is through site-directed mutagenesis. Loss of function through mutation of the 
motif is suggestive of its importance. However, many of the structures in the 5’UTR are 
poorly defined and thus the choice of nucleotides to mutate by site-directed mutagenesis 
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is difficult. A description appeared in 1990 for a method termed as SELEX (systematic 
evolution of ligands by exponential enrichment) (Tuerk and Gold, 1990). In this way, a 
huge number of possible mutations on a particular sequence of interest can be tested at 
the same time rather than testing mutations individually and sequences with functional 
structures can be selected from a pool of random sequences (Ellington & Szostak, 1990; 
Joyce, 1989; Tuerk & Gold, 1990). The SELEX method has been adapted for both in 
vitro and in vivo approaches. 
 
1.2.1.1. In vitro SELEX 
   
 In vitro SELEX involves several rounds of selection for the purification of 
functional RNA molecules from a complex pool or population of RNA variants. One 
round of selection is comprised of three steps: 1. Synthesis of the randomized RNAs. 2. 
Selection 3. Amplification, as described below briefly. A general scheme of in vitro 
SELEX is shown in Figure 7. 
 
1.2.1.1.1. Synthesis of the randomized RNAs  
   
 This step starts with the generation of a complex pool of DNAs that are 
randomized at a particular sequence. For example, if 9 nts (nucleotides) are randomized, 
the starting pool represents 262144 different possible molecules (49 = 262144, where 4 = 
A, C, T, G). The pool of randomized DNAs is transcribed to obtain the pool of 
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randomized RNAs. This pool of RNAs is called the initial pool and is an ensemble of 
functional and non-functional RNA molecules. 
 
1.2.1.1.2. Selection 
   
 The initial pool of RNA molecules with random sequences is separated into pools 
of desired and undesired molecules by the use of various partitioning techniques. As a 
result of partitioning, the complexity of sequences becomes lower in the new pools as 
compared to the initial pool. Subsequently, these pools are subjected to further rounds of 
selection to achieve desired characteristics by enriching it with a great proportion of 
active molecules.  
 
1.2.1.1.3. Amplification 
   
 To initiate every new round of selection, the selected RNA molecules from the 
previous step are used as templates for the synthesis of cDNA by reverse transcriptase, 
followed by amplification by PCR. With subsequent rounds of selection, functional 
sequences/structures dominate the pool and the non-functional sequences/structures are 
discarded. Ultimately, the activity of the pool is increased and the complexity is 
decreased. 
 The last step after the completion of the rounds of selection is to analyze the 
composition of the functional and non-functional pools. This is achieved by isolating 
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individual clones by cDNA cloning, followed by sequencing and or transcribing to 
individual RNAs for further characterization.  
                 
Figure 7. Schematic presentation of in vitro SELEX. 
 
1.2.1.2. In vivo SELEX 
   
 In addition to employing the SELEX method in vitro, one can also use it inside 
the cells, termed in vivo SELEX. Berkhout and Klaver described the in vivo application 
of the SELEX to RNA viruses in 1993 for the first time (Berkhout & Klaver, 1993), after 
which other groups (Doria-Rose & Vogt, 1998; Morris et al, 2002) used it. This approach 
is an exciting tool for understanding the functional role of a sequence/structure in the life 
cycle of a virus describing the biological relevance of that sequence/structure. Using this 
approach, replication-competent viruses can be obtained from a pool of viable and non-
viable proviral DNAs with random sequences at a particular region (Figure 8). 
 The primary step of in vivo SELEX involves the construction of a random pool of 
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full-length infectious DNA clones, which is technically more challenging than 
constructing short randomized DNA templates for in vitro SELEX. Subsequently, this 
pool is transfected and infected into eukaryotic cells and infection is allowed to persist for 
a certain time until only replication-competent viruses survive. After the completion of 
the entire selection for the dominant sequences, two steps are performed. First, selected 
viruses are processed for RNA extraction and cloning for sequence analysis. Second, 
these sequences are cloned into the full-length backbone of the original wt plasmid to test 
individually the impact of these sequences on viral replication. Both in vitro and in vivo 
SELEX methodologies were employed to obtain new structural information on the HIV-2 
packaging and dimerization domains, presented in this dissertation. 
 
 
 
 
 
 
 
 
 
 
Figure 8. Schematic presentation of in vivo SELEX. 
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1.3. Specific aims 
  
 As mentioned before, the pal is a 10-nt palindrome sequence within packaging 
signal and is located upstream of the dimerization signal (Griffin et al, 2001; Lanchy et 
al, 2003a). In this dissertation research, the overall goal was to determine which 
structures and sequences are essential for the regulation of RNA dimerization and 
packaging, with attention focused on the pal region.  This goal was divided into three 
specific aims, which are listed along with the overall findings below.  
 
1.3.1. Specific Aim 1: Characterize the role of 
pal on dimerization in vitro 
  
 Since pal was shown to interfere with the SL1-mediated dimerization in vitro 
(Lanchy et al, 2003a), we hypothesized that pal acts as a regulator of SL1-mediated 
dimerization by base pairing with SL1. To study this hypothesis, we randomized pal and 
selected for those RNAs that were dimerization competent or dimerization-incompetent 
in vitro. This study constitutes specific aim 1 and is presented as a published manuscript 
(Baig et al, 2007) in chapter 2. 
 The first section of the research includes the experimental details about the 
randomization of pal motif in the context of HIV-2 leader RNA and selecting those 
RNAs with impaired and enhanced dimerization properties. The second section provides 
a detailed predicted secondary structure analysis of pal-SL1 region of these selected 
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RNAs. The third section is about the characterization of dimerization properties of a few 
of the individual RNAs. The results of this section provide evidence on the correlation of 
predicted secondary structures of pal-SL1 region with the dimerization properties of 
RNA. Overall, we demonstrate that an extended SL1 structure, which is formed as a 
result of base-pairing interactions between the 3’ side of pal with a sequence downstream 
of SL1, is a regulator of dimerization.  
1.3.2. Specific Aim 2: Characterize the role of 
pal in vivo.  
  
 Since pal is located within the packaging signal and has been shown to regulate 
dimerization in vitro through structural rearrangements, we hypothesized that pal is 
involved in regulating viral RNA packaging.  The third chapter of this dissertation, which 
is an accepted manuscript (Baig et al, 2008) describes the research conducted to study 
this hypothesis. The research employs in vivo SELEX to study the role of 5’ side of pal in 
packaging.  
The first section describes the construction of a library of full-length HIV-2 
proviral DNA genomes with random sequences in 5’ side of pal. The second section 
indicates the selection for replication-competent (viable) viruses from the population of 
viruses that were randomized at the 5’ side of pal. The third section shows that the 5’ pal 
sequences of the viable viruses converged to the consensus sequence GGRGN. The last 
section provides evidence that this sequence at the 5’ side of pal is critical for effective 
genomic RNA packaging and viral replication. 
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1.3.3. Specific Aim 3: Characterize the role of 
pal on RNA-protein interactions in vitro 
  
The predicted secondary structure analysis of pal-SL1 region for selected and 
non-selected sequences from specific aim 2 suggested that extended SL1 is important for 
genomic RNA packaging, when the 5’ side of pal is unpaired and exposed. Because of 
the similarities with known Gag and NC binding preferences, GGAG is likely to be an 
essential element for Gag and NC recognition and binding. 
The fourth chapter in this dissertation includes experiments to study this 
hypothesis. The first section describes the expression and purification of Gag and NC 
proteins and synthesis of two radioactive RNAs corresponding to 5’UTR of HIV-2 
genomic RNA. One of those was an unselected, non-consensus sequence obtained during 
the study of specific aim 2 and was packaging-defective. We hypothesized that the 
packaging defect may be attributable to poor Gag and/or NC binding to the non-
consensus RNA sequence. The other RNA was the wt sequence and was also a selected 
individual in that study. The second section of this chapter shows the binding results 
between RNAs and the purified proteins. Our results indicate that Gag binds 
preferentially to wt RNA as compared to the packaging-defective RNA in vitro, which is 
consistent with in vivo results. 
The fifth and last chapter of this dissertation describes the overall conclusions 
drawn from the research presented here. In addition, it provides some future directions 
for the continuation of studies described in the third specific aim.  
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2.1. Abstract 
 
Genomic RNA dimerization is an essential process in the retroviral replication 
cycle. In vitro, HIV-2 RNA dimerization is mediated at least in part by direct 
intermolecular interaction at SL1 (stem-loop 1) within the 5’ untranslated leader region 
(UTR). RNA dimerization is thought to be regulated via alternate presentation and 
sequestration of dimerization signals by intramolecular base pairings. One of the 
proposed regulatory elements is a palindrome sequence (pal) located upstream of SL1. To 
investigate the role of pal in the regulation of HIV-2 dimerization, we randomized this 
motif and selected in vitro for dimerization-competent and dimerization-impaired RNAs. 
Energy minimization folding analysis of these isolated sequences suggests the 
involvement of pal region in several short-distance intramolecular interactions with other 
upstream and downstream regions of the UTR. Moreover, the consensus predicted 
folding patterns suggest the altered presentation of SL1 depending on the interactions of 
pal with other regions of RNA.  The data suggest that pal can act as a positive or negative 
regulator of SL1-mediated dimerization and that the modulation of base pairing 
arrangements that affect RNA dimerization could coordinate multiple signals located 
within the 5’UTR. 
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2.2. Introduction 
 
Retroviruses package two copies of their positive sense single stranded RNA 
genome into a single viral particle. Analysis of the packaged genomes revealed that the 
two RNA molecules are linked by non-covalent bonds and form a dimeric RNA structure 
inside the viral particle (see reviews; Greatorex & Lever, 1998; Paillart et al, 2004b; 
Russell et al, 2004). The dimeric nature of the genomic RNA has been characterized by 
sedimentation analysis (Cheung et al, 1972) and non-denaturing gel electrophoresis (Fu 
& Rein, 1993). Moreover, electron microscopic studies indicated that the two RNA 
molecules are joined strongly with each other through a region close to their 5' ends, 
termed the DLS (dimer linkage structure; (Bender & Davidson, 1976; Hoglund et al, 
1997)). 
The mechanism of dimerization promoted by the DLS was further studied in vitro 
using RNA fragments encompassing the 5' end of the HIV-1 genomic RNA, which 
showed the spontaneous dimerization of these RNA fragments without any cellular or 
viral proteins (Darlix et al, 1990). The essential motif for dimerization of the HIV-1 
genomic RNA was identified in vitro and called the DIS (dimerization initiation site; 
(Laughrea & Jette, 1994; Muriaux et al, 1995; Paillart et al, 1994; Skripkin et al, 1994)) 
or SL1 (stem-loop 1; (McBride & Panganiban, 1996)). In vitro, this motif mediates 
dimerization between two RNA molecules through a kissing loop interaction (Laughrea 
& Jette, 1994; Paillart et al, 1994; Skripkin et al, 1994) that may proceed further through 
an extended intermolecular interaction to form a stable extended duplex at least when 
short RNA constructs are used (Greatorex & Lever, 1998; Laughrea & Jette, 1996; 
Muriaux et al, 1996a). 
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The dimerization properties of the HIV-2 leader RNA are somewhat different 
from those of the HIV-1 leader. Multiple dimerization elements have been described 
within the HIV-2 leader RNA, including stem loop 1, which is homologous to the HIV-1 
SL1 (Dirac et al, 2001; Lanchy & Lodmell, 2002), and nucleotides within the PBS 
(primer-binding site; (Jossinet et al, 2001; Lanchy & Lodmell, 2002)). Furthermore, a 10 
nucleotide palindrome sequence called pal within the encapsidation signal of the HIV-2 
leader RNA, has been proposed to be involved in dimerization or its regulation in vitro 
(Lanchy et al, 2003a). 
The ability of genomic RNA to dimerize is a potentially important event for key 
steps of the viral replication cycle such as translation, encapsidation, and recombination 
(Abbink & Berkhout, 2003; Baudin et al, 1993; Chin et al, 2005; D'Souza & Summers, 
2004; Darlix et al, 1990; Flynn et al, 2004; Fu et al, 1994; Fu & Rein, 1993; Hibbert et al, 
2004; Hu & Temin, 1990; Jetzt et al, 2000; Mikkelsen et al, 2000; Rein, 1994; Sakuragi 
et al, 2003; Stuhlmann & Berg, 1992). Genomic RNA dimerization and encapsidation 
have been proposed to be regulated through different conformations of the leader RNA 
region that trigger or prevent these two processes. Two alternative conformations have 
been reported in vitro for HIV-1 leader RNA that show different dimerization properties 
(Berkhout & van Wamel, 2000; Huthoff & Berkhout, 2001). One of the proposed 
conformations exists as a rod like structure with a LDI (long-distance base pairing 
interaction) between the poly (A) signal stem loop and SL1 domains (Huthoff & 
Berkhout, 2001), therefore masking the SL1 and inhibiting dimerization. In the other 
proposed conformation, the leader region can refold into a BMH (branched structure with 
multiple hairpins) that exposes both the poly (A) and SL1 hairpins and favors 
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dimerization. Although disruption of the LDI causes phenotypic changes in HIV-1 
replication (Abbink et al, 2005; Ooms et al, 2004), structural evidence for the two 
conformations has been elusive as chemical probing of the HIV-1 genomic RNA 
structure in infected cells and in viral particles did not reveal the existence of a 
predominant LDI conformation (Paillart et al, 2004a). 
In contrast to HIV-1, the HIV-2 leader RNA fragments do not dimerize efficiently 
through SL1 in vitro (Dirac et al, 2002a; Lanchy et al, 2003a; Lanchy & Lodmell, 2002; 
Lanchy et al, 2003b). It has been proposed that similar to HIV-1, monomeric HIV-2 RNA 
can adopt two alternative conformations that sequester and release SL1, respectively 
(Dirac et al, 2002a; Lanchy et al, 2003a). The impaired dimerization of HIV-2 RNA is 
thought to be caused by an energetically favored folding that sequesters SL1 (Dirac et al, 
2002a; Lanchy et al, 2003b). We suggested that the intramolecular sequestration of SL1 
occurs through base-pairing with the upstream 10-nt pal sequence (Lanchy et al, 2003b).  
Since the 10-nt pal sequence (392-401) is located upstream of the SL1 in the HIV-
2 leader RNA (Figure 9) and can affect the SL1-mediated dimerization of HIV-2 leader 
RNA fragments in vitro, we have characterized in the present study the role of pal by 
randomizing this motif and selecting from a population of random-pal RNAs those with 
enhanced or diminished dimerization properties. We cloned and sequenced individual 
RNAs from the selected pools and used their sequences to analyze the functionally 
important secondary structures that might be involved in silencing or enhancing SL1's 
role as a dimerization element. In particular, the predicted folding models suggest that the  
non-native selected pal sequences (denoted pal* to distinguish from the wt pal sequence) 
were involved in different patterns of binding in the monomer and dimer RNA 
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populations. Moreover, the different pal* binding patterns are associated with different 
structural presentation of SL1 that correlated with the observed dimerization abilities of 
the selected RNAs. Our observations underscore the importance of pal* as a regulator of 
dimerization by modulating SL1 presentation. In addition, similarities in the dimerization 
behavior and predicted folding of the monomer pool RNAs with wt RNA suggest a 
general model for pal’s involvement in the regulation of dimerization.   
 
                            
Figure 9. HIV-2 leader RNA and location of the pal and SL1 elements. 
A. The 5’ leader region of HIV-2 ROD genomic RNA is represented with boxes and numbers to indicate 
the landmark sequences with their names indicated above. TAR, poly A signal, C-box, PBS, ψ, SL1, SD, 
G-box and gag represent the trans-activation region, the poly (A) signal domain, C-rich sequence, the 
primer binding site, the encapsidation signal ψ, stem loop 1, the major splice donor site, G-rich sequence, 
and the 5’ end of the Gag protein coding region, respectively. B. A simplified secondary structure of 
nucleotides 380-444. The gray box highlights the 10-nt palindrome sequence (pal) in the encapsidation 
signal and the 6-nt autocomplementary sequence essential for SL1-mediated dimerization in the apical loop 
of the SL1 is outlined. 
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2.3. Materials and Methods 
2.3.1 . Production of pool “0” DNA template  
 
Several PCR reactions and ligation steps were used to build the pool 0 DNA 
library, which was degenerate at nine nucleotides in the pal (palindrome sequence). First, 
a sense primer containing a BamHI site with a T7 RNA polymerase promoter (sBamT7R; 
Table 1) and an antisense primer containing the unique Hpy99I site (nts 388-392)(asHpy; 
Table 1) were used to amplify the first 392-nt long fragment of the HIV-2 leader region 
(ROD isolate, GenBank M15390). Second, a sense primer containing the Hpy99I site 
with the degenerate sequence in pal (sHpy-random; and an antisense primer containing an 
EcoR1 site (asEco561; 
Table 1) were used to amplify the last 169-nt long fragment of the HIV-2 1-561 region 
(PfuUltra High Fidelity DNA polymerase, Stratagene). The 10-nt pal was degenerate at 
only nine nucleotides (393-401), because the first nucleotide (G392) of pal belongs to the 
Hpy99I recognition site used in our cloning strategy and thus needed to be kept intact to 
get cohesive Hpy99I ends of the fragments (Figure 10A). Third, the agarose gel-purified 
PCR fragments were digested with Hpy99I and ligated together using the Quick ligation 
kit (New England Biolabs). Another gel purification was used to purify the correct 
ligation product, i.e. the 392-nt fragment ligated to the 169-nt fragment. Fourth, the 561-
nt long ligation product was re-amplified using sBamT7R and asEco561 primers, gel-
purified and digested with BamHI and EcoR1 to get the pool 0 DNA template. 
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Table 1. Oligonucleotides used in chapter 2.  
The nucleotides forming the Hpy99I site are underlined (5'-CGACG-3'). 
 
2.3.2. Pool 0 RNA synthesis and purification  
 
Pool 0 RNA was synthesized from the pool 0 DNA template with the 
AmpliScribe TM T7 transcription kit (Epicentre).  After transcription, the DNA template 
was digested with RNase-free DNase. The RNA transcripts were purified by 
phenol/chloroform extraction, ammonium acetate and ethanol precipitation followed by 
denaturing gel electrophoresis, excision, and extraction of the 1-561 RNA.  A sample of 
the pool 0 DNA template was sequenced to verify degeneracy of the pal region (data not 
shown). 
 
2.3.3. Selections for dimerization-competent and 
dimerization-impaired RNAs 
   
The selection for dimerization-competent RNAs was carried out essentially as 
previously described (Lodmell et al, 2000).  In this study, additional selections were 
made separately for dimerization-impaired RNAs.  Briefly, an aliquot of the pool 0 
sBamT7R 5’-TAG GAT CCT AAT ACG ACT CAC TAT AGG TCG CTC TGC GGA GAG-3’ 
asEco561 5’-AAG AAT TCA GTT TCT CGC GCC CAT CTC CC-3’ 
sHpy-random 5’-CAA CCA CGA CGN NNN NNN NNT AGA AAG GCG CGG GCC GAG G-3’ 
AsHpy 5’-AGG CAC TCC GTC GTG GTT TGT TCC TGC CGC CC-3’ 
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degenerate RNA was denatured in 8 µl H2O at 90°C for 2 min, then snap cooled on ice 
for 2 minutes. Dimerization was allowed to proceed for 30 min at 55°C after adding the 
dimer buffer (final concentration: 50 mM Tris-HCl, pH 7.5 at 37°C, 300 mM KCl and 5 
mM MgCl2).  Following 30 min of incubation, samples were loaded with 2 µl of 6x 
glycerol loading dye (40 % glycerol, 44 mM Tris-borate, pH 8.3, 0.25 % bromophenol 
blue) onto a 0.8 % agarose gel. Electrophoresis was carried out for 90 min at room 
temperature (24˚C) in 44 mM Tris-borate, pH 8.3 and 1 mM EDTA (0.5x TBE). The 
ethidium bromide-stained gel was visualized on a Fuji FLA3000G Image Analyzer. The 
bands corresponding to the dimer and monomer RNA species were excised from the gel. 
To obtain the templates for further rounds of transcription and selection, a slice of each 
excised band was subjected to RT-PCR (reverse transcription and polymerase chain 
reaction) using AccuScript™ High Fidelity RT-PCR kit (Stratagene). The reverse 
transcription step was performed in a final volume of 10 µl to synthesize the cDNA from 
a 5 µl equivalent slice of each excised band with the asEco561 antisense primer (0.6 
µM), dNTP mix (1 mM of each dNTP), 1x AccuScript™ RT buffer and 0.5 µl 
AccuScript™ High Fidelity RT enzyme according to the manufacturer's protocol. The 
reverse transcription reaction was incubated at 42°C for 30 minutes. The PCR step was 
performed in a final volume of 50 µl containing 4 µl of the cDNA template, 0.2 µM of 
sBamT7R and asEco561 primers ( 
Table 1), dNTP mix (0.2 mM of each dNTP), 1x PCR buffer and 2.5 units of 
PfuUltra™ High Fidelity DNA polymerase (Stratagene). Forty cycles of amplification 
with a 55°C annealing temperature were used. The resulting RT-PCR products were 
digested with BamHI and EcoR1 prior to transcription or cloning. We carried out five and 
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six successive rounds of selections for dimerization-impaired and dimerization-competent 
RNAs, respectively. For sequence analysis, the digested RT-PCR products of the final 
rounds for both selections were ligated to the BamHI and EcoRI sites of the pUC18 
plasmid. The ligation reaction was transformed into competent DH5α Escherichia coli 
bacteria. Sixty individual DNA clones from each selection were obtained by DNA 
isolation from the bacterial colonies and sequenced. 
 
  
 
Figure 10. Randomized pal* sequence and in vitro selection methodology.  
A. Detailed view of randomized pal region of the 561-nt pool 0 RNA used for in vitro selection. The pal 
element is a 10-nt palindrome sequence within the encapsidation signal ψ, located immediately upstream of 
SL1. Nine nucleotides (393-401) in the pal sequence were randomized in the template used for 
transcription of the pool 0 RNAs, while keeping the first nucleotide of pal (G392) constant so as not to 
disrupt the Hpy99I restriction site required for template construction (see Materials & Methods). B. 
Schematic of the SELEX approach used to select and amplify the dimerization-competent and 
dimerization-impaired RNAs from the dimer and monomer pools, respectively. The dimeric and 
monomeric RNAs were partitioned on non-denaturing agarose gel. The dimeric and monomeric RNAs 
were excised from the pool 0 gel and used as the templates for RT-PCR to generate the DNA template to 
transcribe RNAs for the subsequent dimer and monomer pools. This cycle was repeated several times 
separately for the dimer and monomer selections. The solid arrows represent the dimeric and monomeric 
RNAs used for each subsequent round of selection. The dotted arrows represent those RNAs that were not 
processed for selection.  
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2.3.4. Prediction of secondary structures 
 
Mfold version 2.3 (Zuker, 2003) was used to predict the most stable secondary 
structure for 1-561 wild type HIV-2 ROD and the 120 individual clonal 1-561 RNA 
sequences isolated from the final dimer (7th) and monomer (6th) pools. The software used 
is found on the mfold server (http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-
bin/rna-form1-2.3.cgi) (Zuker, 2003). The folding temperature was set at 55˚C since the 
RNAs were incubated at 55°C in our dimerization protocol. The 120 most stable (i.e. 
optimal) secondary structures were visually analyzed and the organization of the pal* and 
SL1 elements and the base-pairing partners of the selected pal* nucleotides (nts 392-401) 
were recorded, allowing segregation of the 120 pal* sequences into distinct structural 
groups (see Figure 12 and Table 3). 
2.3.5. Synthesis and purification of selected    
     RNAs 
 
Eight clones out of the 60 individual DNAs from each final dimer and monomer 
pools were chosen for characterization of dimerization properties. The plasmids were 
linearized with EcoRI prior to in vitro transcription. RNAs were synthesized with 
AmpliScribe TM T7 transcription kit (Epicentre). After synthesis, RNAs were purified by 
ammonium acetate precipitation and size exclusion chromatography (Bio-Gel P-4, Bio-
Rad), followed by ethanol precipitation. 
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2.3.6. In vitro dimerization of selected RNAs 
 
The dimerization efficiency of the 16 individual clonal RNAs was checked by 
non-denaturing gel electrophoresis as described for the in vitro selection of dimer and 
monomer pools. 
2.3.7. RNA solution structure probing 
 
In a standard experiment, 5 picomoles of 1-561 wild type HIV-2 genomic RNA 
was heated in water for 2 min at 90˚C, then quench cooled on ice. The folding was started 
by the addition of dimer buffer. After 0, 4 or 20 min incubation at 55˚C, dimethylsulfate 
(Aldrich) was added to the RNA and the mixture incubated 2 min at room temperature 
(27˚C). The final concentration of DMS was 0.5%. Chemical probing was stopped by the 
addition of 10 µg glycogen, EDTA (2 mM, final concentration), sodium acetate (300 
mM, final concentration), followed by two and a half volumes of absolute ethanol. After 
a 30-min precipitation at –25˚C, the samples were pelleted by centrifugation at 15,000 
rpm for 30 minutes, ethanol washed, vacuum dried, and resuspended in water. One fourth 
of the resuspended material was then reverse-transcribed with the avian myeloblastosis 
virus reverse transcriptase (Promega) and a 5' end-32P-labeled radioactive DNA 
oligonucleotide primer (complementary to nts 470-494). After a 30-min primer extension 
at 42˚C, the samples were precipitated as described above and the dried pellet was 
resuspended in formamide loading and tracking dye and analyzed by denaturing PAGE. 
A DNA sequencing of the plasmid DNA used for the transcription was loaded together 
with the primer extension to identify the modified nucleotides. 
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2.4. Results 
2.4.1. Construction of pool “0’ RNA and    
selections for dimerization-competent and          
dimerization-impaired RNAs 
 
The HIV-2 leader RNA fragment (561-nt long) was previously shown to dimerize 
inefficiently through SL1 in vitro (Lanchy & Lodmell, 2002; Lanchy et al, 2003b). The 
existence of an alternative conformation of the monomeric leader RNA was proposed to 
be responsible for this inability to dimerize efficiently, in which a short-range 
intramolecular interaction (pal-SL1) occludes the SL1 dimerization element (Lanchy et 
al, 2003a). The 10-nt pal sequence (392-401) is located upstream of the SL1 in the HIV-2 
RNA (Figure 9). To further characterize the role of pal, we designed a 1-561 RNA 
construct harboring a randomized pal to determine how pal could act as a regulatory 
element for SL1. Nucleotides 393-401 of pal were randomized within the DNA 
transcription template used in this study. Hence, the pre-selection (pool 0) RNA species 
were 561-nt long and harbored a 392GNNNNNNNNN401 sequence (where N has an equal 
probability of being A, C, G, or U) instead of the wt 392GGAGUGCUCC401 sequence 
(Figure 9B, Figure 10A) Randomization of this region was verified by sequencing (data 
not shown).  
An in vitro selection/amplification technique was used to enrich the randomized 
populations for RNAs that were dimerization-competent or-impaired. The approach used 
in the selections of both pools is explained in Materials and Methods and in (Figure 10B). 
Pool 0 RNA was fractionated into dimer and monomer species by non-denaturing gel 
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electrophoresis. RNA migrating as a dimer species was excised from the gel, subjected to 
RT-PCR, transcription, and the resulting RNA was used in a subsequent round of 
selection for dimerization-competent RNAs. Likewise, RNA migrating as a monomer 
species was similarly processed and the re-amplified RNA was used in a subsequent 
round of selection for dimerization-impaired RNAs (Figure 10B). After initial 
fractionation of pool 0 for dimer and monomer RNA species, further selections were 
made separately to minimize cross contamination. The percentage of RNA migrating in 
dimeric form increased with the consecutive rounds of dimerization-competent RNAs 
selection (Figure 11A). We stopped the dimerization-competent RNAs selection when 
the percentage of dimer reached a plateau and remained constant for several rounds of 
selection (Figure 11C). In parallel, the percentage of dimer decreased with the successive 
rounds of dimerization-impaired RNAs selection (Figure 11B). We discontinued the 
selection when the percentage of dimer remained the same for several rounds of selection 
(Figure 11C). 
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Figure 11. Evolution of dimerization characteristics after repeated rounds of selection for 
dimerization-competent and dimerization-impaired pool RNAs.  
A. A non-denaturing dimerization gel is shown to represent the pool 0 (unselected RNA) and successive 
rounds of selection (1st, 2nd, 4th, 5th and 6th) of the dimer pools. The top band, migrating as dimer for pool 0 
RNA, was used as the starting material for each subsequent round of selection for dimerization-competent 
RNAs, while the bottom band for pool 0 RNA was used during the separate selections for dimerization-
impaired RNAs. The dimerization of the wt RNA is shown for comparison. B. A non-denaturing 
dimerization gel is shown to represent the pool 0 (unselected RNA) and successive rounds of selection (1st, 
3rd and 5th) of the monomer pools. The wt RNA is also shown for comparison. C. The percent dimer yield 
from the dimer pools (open squares) and from the monomer pools (open circles) was quantified by 
phosphorimager scanning and analyzed with Fuji Image Gauge v3.3 software. 
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2.4.2. Interactions of in vitro selected pal 
sequences (pal*) within the 1-561-nt long RNA  
 
The resulting cDNAs from the last dimerization-competent (6th round) and 
dimerization-impaired (5th round) selections were cloned into pUC18 for either 
sequencing or expression of the individual clonal RNAs. Sixty clones from each pool 
were sequenced and subjected to computer assisted lowest energy folding. We called 
these two pools monomer and dimer pools, since they originated from the last 
dimerization-impaired and -competent RNA selections, respectively. Mfold version 2.3 
(Zuker, 2003) was used to predict the most stable secondary structure at 55°C for each of 
the 120 individual sequences. The folding temperature was set at 55˚C since the RNAs 
were incubated at 55°C in our selection protocol. The 120 optimal secondary structures 
were visually analyzed and the organization of the pal* and SL1 elements and the base-
pairing partners of the selected pal* nucleotides was recorded and shown in (Figure 12) 
by model structures and dots adjacent to the leader RNA schematic, respectively. 
One striking pattern revealed by mfold analysis was the reproducible and 
relatively small number of intramolecular interactions that variant pal* made with 
upstream and downstream RNA sequences, as evidenced by the peaks of dots in (Figure 
12). Distinct structural groups are formed by pal* interacting with either the C-box, 380, 
SL1, 444, or 500-regions. We included another structural group called free pal*, 
representing the variant pal* sequences where none of pal* nucleotides are base-paired in 
the optimal mfold-predicted structure (7 and 13% of dimer and monomer pool sequences, 
respectively; Table 3). The major partners of pal* among RNA species isolated from the 
dimer pool were C-box, 380-region and SL1 (Figure 12A). They represent 27, 45, and 
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20% of the dimer pool sequences respectively (Table 3). In the monomer pool, the major 
regions predicted to base-pair with pal* included the 380, SL1, 444 and 500-regions 
(Figure 12B). They represent 22, 20, 30, and 12% of the monomer pool sequences 
respectively (Table 3). 
Another feature revealed by mfold analysis was that the structural environment of 
SL1 differs between dimer and monomer pools and correlates with the pal*-defined 
structural groups. In the dimer pool, SL1 is often presented as an individualized stem-
loop structure (80% of the dimer pool sequences; Table 3) and (Figure 12A), while pal* 
interacts with sequences located upstream of itself, either the C-box element or the 380-
region (27% and 45%, respectively; Table 3). 
Although some pal* binding partners are located upstream of pal* (25%; Figure 
12B; Table 3), monomer pool sequences are characterized by increased interaction of 
pal* with sequences located downstream of SL1, either with the 444-region or the 500-
region (30% and 12%, respectively; Figure 12B; Table 3). The direct consequence is a 
local increase of SL1 stability, which may regulate HIV-2 RNA dimerization (see 
Discussion). 
Interestingly, 20% of both monomer and dimer pools sequences optimal 
structures sequester SL1 by direct base pairing with part of SL1 (pal*-SL1; Table 3; 
Figure 12). The pal*-SL1 interactions could be further divided in two subgroups, 
depending on whether pal* interacts with the 5' stem of SL1 or its loop and 3' stem 
(Figure 12, compare the pal*-SL1 structures in panel A and B). Moreover, the pal*-(5' 
stem SL1) interactions are more represented among dimer pool sequences than among 
monomer pool sequences (13% and 7%, respectively; Table 3).  
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Figure 12. Summary of the base-pairing interactions of in vitro selected pal* in the predicted optimal 
1-561 RNA structures from the last dimer pool (panel A) and monomer pool (panel B) individual 
sequences.  
A. The secondary structures of the selected RNAs from the dimer and monomer pools were predicted using 
the mfold program, v2.3 at 55˚C (Zuker, 2003). The base-pairing partners of pal* (nts 392-401) were taken 
from the most stable predicted structure for each of the 120 cloned sequences. Nucleotides predicted to 
interact with pal* in all of the most stable secondary structures are indicated by dots above the leader 
region schematic (i.e., one dot equals one base-pair with one pal* nucleotide). The high peaks of dots 
represent the major partners of pal*, and include the C-box (nts 186-199), the 380-region (nts 358-390), 
SL1 (nts 409-436), the 444-region (nts 437-444) and the 500-region (nts 490-514). The major pal* binding 
regions for both selections are indicated with brackets below panel B. Secondary structure of pal*, SL1, 
and pal*-interacting partners for the structural groups are indicated above the dots schematic in both panels. 
Only the pal* nucleotides that are consistently base-paired in each structural group are indicated. Y 
indicates a pyrimidine residue (C or U). 
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T A C C C T C G T G T G T G T A C C C T C G T G T G T G
D01/45/60 G T A G G A G A G A M18 G A G T T G G G C T
D17 G G A G A G A C A T M33 G A G T T T G G G A
D54 G G G A G A G A T A
D23 G T G G A G A G A T
D41 G G G A G C A T A A G C A G C A C C A A A A C A A
D51 G G G A G C A T T A M25 G G G T A C T T C T
D29 G G G A G C A A T G M28 G T C C G G T A T G
D30 G G G A G T A C A A M53 G T G G A T G T A C
D31/38 G G A G C A C A C A M20 G A T C C T G G A T
D56 G G G A G C T A A C M56 G A T C G T G A A T
D04 G G G A G A G A T A M32 G C A A A T C G T C
D39 G T G C A C T T A G M01 G G C A T C G A G T
D03 G G G G C G T T T A M51 G A G T A T G C A G
M58 G G A A C G G T T G
M23/43 G T T T T T A A T G
G C A G C A C C A A A C A A G G A M16 G T G T G A T C T A
D14 G T G G T T T A C A M12 G G G T G T T A A T
D02/34 G T G G T G C T A T
D22 G T G G T C A T A C
D10/21 G G T T T G C T T A A G C C G G G C G C G G A A A G
D19 G G T T G G A T G C M07 G G T C C A T G T C
D44 G G T C A C G T A C M26 G C G C A C A T T T
D42 G C G T T G G T T A M29 G A C T A T G C A T
D06 G G A A G G T T A T M50 G G C T T C T C T T
D40 G A T G G T T C G T
D58 G A G G T T C A G T
D50 G C C T G G T T T T C G A C G G A A A C C A
D18 G A T C A G G G T T M04/15 G A G T T T A T G G
D57 G C G A A T G T G T M54 G G T C A A T G G T
D12 G T C G T G G A A T M11 G G C C T T A A G G
D16 G T A T C G T A T G M13 G C G C T C G A T A
D05 G G A T G A C G T A M55 G C A G A C G G A T
D48 G A T G C G T G T A M08 G C G T G C A C G T
D59 G G A C T A T C A A M14 G G C C T T G G T A
D35 G G G A T G T T A A
D46/47 G C C T A C A A C T
D25 G C C C A C A T A G G A G G A G G G C G A G G T G T G C G A C
D09/11 G C C G T C T T C G M10 G C T T T G T T A G
D53 G T G C T C A A A G M40 G C T C T T T G A G
M21 G T T T G A C A A T
M24 G T T T C A T T T A
A G C C G G G C G C G G A A A G A T C M27 G C A T T G C T C T
D49 G C G A G G A T T T M05 G A C G A G C T T A
D13 G C G C A A C T T T M45 G T T C A C A T G C
D37 G C G T C C T T C G M52 G A C G T G T A G C
D24 G A T T T T T G C G M47 G T A C T A C C T T
D28 G G A C T G T G T A M41 G C A G A A G C A T
D07 G G T C C T T G C A M02 G A G C T A C A A A
D36/43 G C C T G G T T T T M38/42 G A C C T C C A C A
M48 G A G T C C A T T C
M37 G A A T C C A T T G
C G A C G G A A A C C M57 G G C C A T T T A T
D32/33 G G A A A T G T G G M34/39 G C A A G T A C G T
D55 G T G A G A G A A T
D08 G C G A T C T T G A
C C G A T G T C A A
M06 G G T T A C A A T T
G A G G A G G G C G A G G T G T G C G M44 G G T T A C C C A G
D26 G G A C T C C T T T M22/31 G G C T A A G T T C
M36 G A G T C A T A G T
M03 G T T T C G G T A G
C C G A T G T C A A M59 G G A T A T C T G T
M30 G A C T G A A A C G
M35 G A A T C G G C A A
M19/46 G A A G C G A T A G
D20 G A G A T T T A G C M49 G A G C A T T A C A
D27 G A T T T T A A A C M17 G T A A C T T C C C
D15 G A A C A A G A G A M60 G G A A G T A A G T
D52 G A T G A G T A A A M09 G A T T A T A A T G
392
 pal*- SL1 (5' stem) 
392
 pal*- 444-region
pal*-none (free pal*)
no target
451
 pal*- 500-region 
498
no sequence
 pal*- SL1 (5' stem) 
419
 pal*- SL1 ( loop, 3' stem) 
434
Dimer pool selection Monomer pool selection
 pal*- SL1 ( loop, 3' stem) 
 pal*- C-box 
419
 pal*- 380-region 
 pal*- C-box
 pal*- 380-region 
193193
 pal*- 444-region 
 pal*- 500-region 
pal*-none (free pal*)
no target
434
451
498
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Table 2. Structural groups of the individual pal* sequences from monomer and dimer pool selections.  
M01-M60 and D01-D60 represent the selected pal* sequence of the 120 clones isolated from the final 
dimer (left panel) and monomer (right panel) pool selections written in a 5' to 3' orientation. The pal* 
sequence also includes the constant G392. The optimal (i.e. most stable) predicted secondary structures of 
the 120 individual clones were visually analyzed and the organization of the pal* and SL1 elements was 
recorded, allowing segregation of the 120 pal* sequences into distinct structural groups as described in 
Materials and Methods. Duplicated or triplicated sequences are represented by only one row (for example, 
D01/45/60). The sequence of the target region is indicated below the name of each structural group together 
with the number of the 3' nucleotide number, in a 3' to 5' orientation. The names of the individual clonal 
RNAs (M01-8 and D01-8) tested for dimerization are bolded. In order to highlight base-pairing consensus 
in each structural group, pal* nucleotides base-paired to target nucleotides in the predicted structures are 
aligned relative to the indicated target sequence. For example, a majority of sequences in the dimer pool's 
pal*-380-region group showed a 5'-GGTT motif base-paired to a target 3'-386-CCAA motif. 
     
 
 
Pool selection 
Dimer Monomer Structural groups 
 (%)  (%) 
pal*-C-box 27 3 
pal*-380-region 45 22 
SL1: 5' stem 13 7 
pal*-SL1 SL1: loop, 3' 
stem 7 13 
pal*-444-region 1 30 
pal*-500-region 0 12 
pal*-none (free pal*) 7 13 
Total 100 100 
  
Table 3. Proportional representation of each structural group in the final dimer and monomer pools.  
The percentage are obtained from the inventory of the structural organization of the pal* and SL1 elements 
in the mfold-predicted optimal structures of the individual monomer and dimer pools selected sequences 
(60 each; see Table 2 and Materials and Methods for details). 
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2.4.3. Characterization of the RNAs isolated 
from the last dimer and last monomer pools 
 
Sixteen sequenced DNA plasmid clones, chosen from the last dimer and monomer 
pool selections were transcribed into pure clonal RNAs. These clonal RNAs were 
characterized for their dimerization properties by non-denaturing gel electrophoresis. The 
HIV-2 leader RNA was shown previously to be dimerization-impaired (Lanchy et al, 
2003a). As expected, the dimerization yield of all eight clonal RNAs (M01-8) from the 
monomer pool selection was quite similar to the wt (Figure 13A, compare lanes 1 and 2-
9) whereas the level of dimerization for six of the eight clonal RNAs (D01-6) from the 
dimer pool selection was higher than wt (Figure 13B, compare lanes 1 and 2-7). The 
dimerization efficiency of the other two clonal RNAs (D07 and D08) was similar to wt 
(Figure 13B, compare lanes 1 and 8-9). Although D07 and D08 RNAs were isolated from 
the last dimer pool selection, their impaired dimerization yields suggest that either they 
were selected as heterodimers with more dimerization-competent RNAs, such as D01-6 
(Figure 13B), or that the stringency of the selection allows carryover of some monomer 
RNA species at each round. In fact, the re-partitioning of RNAs into dimer and monomer 
bands at each round, even though the RNA at each round is derived from template 
originating from solely dimer (or monomer) RNA in the previous round, suggests that the 
RNAs can adopt dimerization-competent or -impaired conformations. 
Finally, analysis of the structural groups to which the 16 clonal RNAs belong, 
showed the same correlation between structural groups and dimerization phenotypes as 
the one we observed for the 120 sequenced individual clones (Table 2). Moreover, D07 
and D08 belong to the pal*-SL1 group, a group represented equally in both monomer and 
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dimer pools (20%; Table 3), reinforcing the hypothesis that these were selected in the 
dimer pool as heterodimers or that they emerged through the selection despite their 
marginal dimerization capacity (see above). 
                         
                         
Figure 13. Characterization of selected RNAs from each of the last dimer and monomer pools.  
Eight RNAs from each pool were selected to characterize their behavior in standard dimerization assays. A. 
Clonal RNAs from the final monomer pool are represented by M01-M08. Lanes 2-9 show the dimerization-
impaired RNAs and lane 1 shows the wt RNA. B. Clonal RNAs from the final dimer pool are represented 
by D01-D08. Lanes 2-7 show the dimer-competent RNAs (D01-06). Lanes 8 and 9 show the dimerization-
impaired D07 and D08 RNAs that persisted during the selection for dimerization-competent RNAs and 
lane 1 represents the wt RNA. 
 
 
2.4.4. Wild type 1-561 HIV-2 RNA solution 
structure probing 
 
To examine the conformation(s) of the wt HIV-2 leader RNA in solution, we 
performed chemical probing of the accessibility (reactivity) of the adenine residues in 
dimer buffer at 55˚C over time (0, 4, or 20 min; Figure 14A). Since the level of tight 
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dimers is low over the first 20 minutes of folding at 55˚C (Lanchy et al, 2003a), this 
experiment was designed to investigate the conformation of the monomeric RNA species 
together with the SL1-mediated kissing loop dimer species, which can also form under 
these conditions. Because solution structure probing yields data on the average 
accessibility of each nucleotide, the readout potentially represents the superimposed 
reactivities of several distinct conformations if more than one conformation exists in the 
reaction. 
Indeed, most adenine residues of the pal and SL1 elements are rather accessible to 
dimethylsulfate (DMS) methylation (on the N1 atom of their Watson-Crick side; see 
(Ehresmann et al, 1987) for review)) (Figure 14). The most reactive adenine is A427 in 
SL1's loop and the most unreactive is A387 located upstream of pal (Figure 14). 
Furthermore, the A423 residue in SL1's palindromic sequence is weakly reactive, 
suggesting that a majority of RNA molecules may be involved in a "kissing" SL1 loop-
loop interaction (loose dimers), since we know that only a small minority form tight 
dimers after 20 min of incubation (see Discussion and (Lanchy et al, 2003a)). 
Finally, comparison of the change of reactivities over time (Figure 14A, lanes 2 to 
4) indicated that the structure involving the pal and SL1 elements formed fast and did not 
change drastically during the first 20 min of folding, except that the A387 residue became 
unreactive after 4 min (Figure 14A). The chemical structure probing results are consistent 
with the extended SL1 model (Figure 14B). 
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Figure 14. DMS probing of the pal and SL1 elements in the wild type HIV-2 leader RNA.  
A. Wild-type 1-561 RNA was denatured, then incubated in the presence of dimer buffer at 55˚C for the 
times indicated. DMS was then added (0.5% final concentration) and incubation was continued at 27˚C for 
2 min. Reactions were stopped and primer extensions were performed to visualize the sites and the 
intensities of adenine residues modifications as described in Materials and Methods (lanes 1 to 4). Lanes A, 
C, G, U  represent the DNA sequencing of the plasmid DNA used to synthesize the RNA. The pal (nts 392-
401) and SL1 (nts 409-436) regions are indicated by vertical lines along the DNA sequencing lanes. B. 
Summary of the principal nucleotide reactivities superimposed on a secondary structure model of the pal 
and SL1 elements for experiments done in this study (closed stars) or in previous publications: open stars 
for kethoxal probing of the guanine residues (Lanchy et al, 2004), open triangles for the single-strand-
specific T1 nuclease (Damgaard et al, 1998), and open circles and closed triangles for DMS and T1 
nuclease, respectively (Dirac et al, 2001). The boxed nucleotides indicate a lack of reactivity of the 
indicated adenines (this work) or guanines (Lanchy et al, 2004). The number of stars, triangles, or circles 
juxtaposed to a residue represent the relative levels of reactivity of this residue vis-à-vis the probing reagent 
(the stronger the reactivity, the greater the number of symbols). 
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2.5. Discussion 
 
Among the compact genomes of the RNA viruses, the viral RNA encodes not 
only viral proteins, but also non-coding structural motifs that help to direct and regulate 
replicative functions. Because these regulatory entities need to be active only transiently, 
we and others have hypothesized that structural rearrangements of non-coding RNA lead 
to the alternate presentation and sequestration of signals in the HIV 5' untranslated leader 
region (Berkhout & van Wamel, 2000; Dirac et al, 2002a; Huthoff & Berkhout, 2001; 
Lanchy et al, 2003a; Lanchy et al, 2003b).  We previously presented evidence that pal 
can interact with SL1 to inhibit HIV-2 RNA dimerization in vitro, but details of the 
interaction were unknown (Lanchy et al, 2003a). Because of the high degree of 
conservation of nucleotides in the region, comparative analysis of HIV-2 and SIV 
sequences was of little use. In vitro evolution of RNA molecules provides a convenient 
way to generate an artificial phylogeny of functionally similar molecules (Ellington & 
Szostak, 1990; Joyce, 1989; Tuerk & Gold, 1990).  
By randomizing pal and selecting for molecules that were either dimerization-
competent or -impaired, we could examine the ability of the pal region to regulate the 
SL1 dimerization signal without making a priori assumptions about structures involved. 
During the course of the study, we evolved pools of RNAs that had two distinct 
dimerization phenotypes. Mfold-mediated optimal secondary structure folding of 120 
individual RNAs from these pools displayed patterns of intramolecular interactions with 
predictive value with respect to dimerization properties, at the level of both selection 
pools and individual clonal RNAs. In addition, similarities in the dimerization phenotype 
and predicted folding of the monomer pool RNAs with wt RNA suggest a general model 
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for pal’s involvement in the regulation of SL1-mediated HIV-2 RNA dimerization in 
vitro. 
Analysis of the lowest energy predicted folding structures for members of each 
evolved population provided general as well as specific insight into potential regulatory 
base-pairing interactions. The observation that most of the pal* interactions were local 
upstream and downstream base pairing was striking and in line with very recent 
observations of essential interactions of the pal in viruses in cell culture (see below). 
Although such predominance of local base pairing structures could not have been 
predicted, on theoretical grounds it is satisfying. To avoid large thermodynamic barriers 
against switching between conformations it is likely that regulatory conformational 
rearrangements are nearly isoenergetic and that switching between conformations should 
involve rearrangement of a limited number of base pairs; such criteria are most easily 
satisfied when base pairing changes are localized to a given domain.  Furthermore, in the 
original population of randomized pal variants, the potential existed for pal* to hybridize 
anywhere along the leader region. The fact that discrete and predominantly local base 
pairing arrangements were found after selection suggests that either other arrangements 
were irrelevant to the selection or that the native folding of the 1-561 RNA limited the 
access of other regions of the leader RNA for hybridization with pal*, for instance the 
intrinsically stable TAR and PBS domains (encompassing nts 1-123 and 197-379, 
respectively (Berkhout & Schoneveld, 1993)). 
Although most pal* base pairing involved short-range interactions with partners 
located less than 45 nts upstream and downstream (Figure 12), two exceptions were 
observed in both dimer and monomer pools. The first example is represented by 27% of 
 53 
the dimer pool sequences (pal*-C-box; Table 3), where pal* was predicted to hybridize 
with the so-called C-box (nts 186-199; Figure 12A and Table 2), an element located 
between the poly A signal and PBS domains that we previously showed is capable of 
modulating dimerization through interactions with the G-box located at the 3’ end of the 
leader RNA (Lanchy et al, 2003b). This result corroborated previous observations 
because pal* hybridizing to the C-box had the same effect on dimerization as 
mutagenesis of the C-box or hybridization of a small complementary oligonucleotide. We 
hypothesize that binding of pal* to the C-box increased the accessibility of SL1 for 
intermolecular interactions, thus explaining the enrichment of C-box-complementary pal* 
sequences (Table 2) in the dimer pool selection (27% versus 3% in monomer pool; Table 
3). 
The other example of a non-local base pairing interaction came from a structural 
group comprising 12% of the final monomer pool sequences (pal*-500-region; Table 3), 
where pal* was predicted to interact with the 500 region (nts 490-514; Figure 12B; Table 
2). Although they are slightly different, we hypothesize that the structure centered around 
SL1 in pal*-500-region clones is functionally similar to the one in pal*-444-region clones 
with regard to their effect on SL1 presentation (Figure 12B). Indeed, the 445-485 region 
folds into two stable and conserved stem-loop structures (ψ1 and the major splice donor 
site stem-loop (Dirac et al, 2002b)) that, together with the pal*-500-region, form a 
constrained domain structurally extending SL1 in a way similar to the pal*-444-region 
fold. Such a constrained SL1 may impair the transition between monomers and tight 
dimers (see below), explaining the presence of the pal*-500-region selected RNAs in the 
monomer pool (12% versus none in dimer pool; Table 3).  
 54 
The precise secondary structure(s) of the SL1 domain have not been definitively 
established for HIV-2 leader RNA, compared to the homologous region in HIV-1 (see 
below and (Shen et al, 2000; Shen et al, 2001)). Several secondary structure models have 
been proposed, some of which correspond to the structures predicted in this work. First, 
wt pal may interact with upstream nts 376-386 and form a stem-loop located between the 
PBS domain and SL1, similar to the pal*-380-region structure shown in (Figure 12A). 
This structure was proposed to form or to be part of a strong encapsidation signal for the 
HIV-2 genomic RNA (Griffin et al, 2001). Second, wt pal may interact with part of SL1, 
similar to the pal*-SL1 structures described in (Figure 12A). The altered presentation of 
SL1's palindromic sequence may lead to a decrease of its dimerization capacity (Lanchy 
et al, 2003b). However, our present study using pal*-randomized RNAs found that the 
pal interaction with the 5' side of SL1 was not frequently detected and, surprisingly, was 
slightly more represented in the final dimer pool (13% and 7% in dimer and monomer 
pools, respectively; Table 3). Third, the 3' end of wt pal may interact with a 5' GGAGC 
motif located downstream of SL1 ((Dirac et al, 2001; McCann & Lever, 1997) and Figure 
14B) and form a structure similar to the one found in pal*-444-region species, which we 
called the extended SL1 (Lanchy & Lodmell, 2007). 
Two interesting outcomes of this study are that the dimerization-impaired 
population is enriched with RNA species (30% of the monomer pool sequences; Table 3) 
showing a predicted, extended SL1 structure (i.e., the pal*-444-region; Figure 12B) and 
that the wild type HIV-2 pal and SL1 elements may fold into a similar structure (Figure 
14B). Wild type RNA, in line with this observation, forms tight dimers rather 
inefficiently, to an extent similar to the yields of monomer pool RNA species (Figure 
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11B) and (Figure 13A), yet SL1 in the extended SL1 structure seems clearly presented in 
as an individualized stem-loop with its palindromic sequence in the apical loop (Figure 
14B). This apparent paradox between a presentation of SL1 apparently optimal for 
dimerization and an impaired dimerization phenotype may be explained if one considers 
both the mechanism of SL1-mediated tight dimerization and the relative stabilities of the 
SL1 structures. Although the mechanism of the transition between monomers and tight 
dimers is still a matter of discussion, studies using a 39-mer HIV-1 SL1 or larger leader 
RNA fragments revealed that this transition could be regulated by the stability of the stem 
of SL1 during the transition from kissing loops dimers to tight dimers in vitro (Baba et al, 
2001; Bernacchi et al, 2005; Huthoff & Berkhout, 2002; Laughrea et al, 1999; Mujeeb et 
al, 2007; Muriaux et al, 1996b; Shubsda et al, 1999; Takahashi et al, 2000). Accordingly, 
the increased stability of extended (-11.3 kcal/mol) versus short (-7.5 kcal/mol) HIV-2 
SL1 structures could have a similar negative effect on tight dimerization efficiency. 
Furthermore, the extended SL1 structure is even more stable in HIV-2 than the 
comparable 39-mer HIV-1 SL1 (-11.3 and -6.4 kcal/mol, respectively; mfold v2.3, 55˚C; 
data not shown), which could increase the energy barrier of the transition from kissing to 
tight dimers. 
Although the extended SL1 structure characterized only one of the different RNA 
structural models revealed during the in vitro selections, recent results suggest that this 
conformation of the SL1 domain is functionally important in vivo. In particular, we 
showed that the formation of the extended SL1 structure is necessary for HIV-2 
replication and genomic RNA encapsidation (Lanchy & Lodmell, 2007). Our 
experiments showed that one important role of the 3' end of pal is to base-pair with the 5'-
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GGAGC motif located downstream of SL1 and that this interaction is necessary for an 
effective genomic RNA encapsidation to occur (Lanchy & Lodmell, 2007). Although a 
strong selective pressure during viral replication for an adenine at position 394 was 
observed upon mutation to a guanine residue (Lanchy & Lodmell, 2007), the precise role 
of the 5' end of pal is less understood. Nevertheless, it is notable that the extended SL1 
structure is surrounded by two 5'-GGAG motifs, including one in pal  (Figure 14B). It is 
possible that these purine motifs might be involved in the specific RNA-protein 
interactions taking place during genomic RNA selection and encapsidation. Likewise, 
deletion mutagenesis studies suggest that an extended SL1 element is involved in 
encapsidation and dimerization of the SIVmac239 genomic RNA (Strappe et al, 2003; 
Whitney & Wainberg, 2006). 
In conclusion, our study shows that a few nucleotide changes in the pal element of 
HIV-2 leader RNA leads to altered dimerization phenotypes in vitro. The efficiency of 
SL1-mediated tight dimerization seems to correlate with the folding of the pal and SL1 
elements, especially with the degree of structural constraint around the SL1 element. 
Extrapolating to wild type, our results suggest that the monomeric form of HIV-2 leader 
RNA adopts several local conformations that regulates the usage of SL1 as a dimerization 
element (Figure 15). Factors that contribute to the transition from dimerization-impaired 
to dimerization-competent RNA species possibly include viral proteins binding to this 
dynamic region, either Gag or NC or both (Figure 15) (Clever et al, 2000; D'Souza & 
Summers, 2005). Testing the protein-RNA interactions in this region represents our next 
endeavor (Figure 15). 
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Figure 15. Model of pal’s regulatory function in HIV-2 leader RNA SL1-mediated dimerization. 
Different conformations of the pal and SL1 elements and different stages of the RNA tight dimerization 
process are represented. The top left structure corresponds to the extended SL1 structure where the 3' end 
of pal base-pairs to a sequence immediatly dowstream of SL1 (Figure 14B and (Dirac et al, 2001)). The top 
right structure shows individualized intra-ψ and SL1 small stem-loop structures (Figure 12A and (Griffin et 
al, 2001)). The dimerization-impaired phenotype for RNAs bearing extended SL1 may be due to a 
thermodynamically disfavored transition from kissing loop dimers to tight dimers, compared to 
dimerization-competent RNA species. However, one cannot rule out that a favored folding of extended SL1 
may further amplify the dimerization-impaired phenotype of wild type HIV-2 leader RNA during in vitro 
dimerization assay. Finally, the virally encoded nucleocapsid protein NC and its Gag polyprotein precursor 
have RNA chaperone activity and may play a role in either the initial intramolecular folding or the different 
stages of SL1-mediated RNA dimerization. 
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3.1. Abstract 
 
The packaging signal (ψ) of HIV-2 is present in the 5’ non-coding region of RNA 
and contains a 10nt palindrome (pal; 5'-392-GGAGUGCUCC-3’) located upstream of the 
dimerization signal stem loop 1 (SL1). Pal has been shown to be functionally important 
in vitro and in vivo. We previously showed that the 3’ side of pal (GCUCC-3’) is 
involved in base pairing interactions with a sequence downstream of SL1 to make an 
extended SL1, which is important for replication in vivo and the regulation of 
dimerization in vitro. However, the role of 5’ side of pal (5’-GGAGU) was less clear. 
Here we characterized this role using an in vivo SELEX approach. We produced a 
population of HIV-2 DNA genomes with random sequences within the 5’ side of pal and 
transfected these into COS-7 cells. Viruses from COS-7 cells were used to infect C8166 
permissive cells. After several weeks of serial passage in C8166 cells, surviving viruses 
were sequenced. On the 5’ side of pal there was a striking convergence toward a GGRG 
consensus sequence. Individual clones with consensus and non-consensus sequences 
were tested in infectivity and packaging assays. Analysis of individuals that diverged 
from the consensus sequence showed normal viral RNA and protein synthesis but had 
replication defects and impaired RNA packaging. These findings clearly indicate that the 
GGRG motif is essential for viral replication and genomic RNA packaging.  
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3.2. Introduction 
 
 The 5' leader RNA of retroviruses is involved in the regulation of many essential 
steps of the retroviral replication cycle. These steps include transcription, splicing, 
translation, genomic RNA dimerization, packaging, and reverse transcription (Abbink & 
Berkhout, 2008; Buck et al, 2001; Clever et al, 1999; Laughrea et al, 1997; McBride & 
Panganiban, 1996; McCann & Lever, 1997; Miele et al, 1996; Ohlmann et al, 2000; Patel 
et al, 2003). RNA packaging is a critical step during which two molecules of full length 
genomic RNA are encapsidated into the budding virion in the form of a dimer (see 
review; Rein, 1994). Furthermore, packaging is a highly selective and specific process in 
which unspliced genomic RNA is preferentially incorporated in viral particles over a vast 
excess of cellular mRNAs and spliced viral RNAs (Linial & Miller, 1990; Luban & Goff, 
1994). This selectivity occurs through the interaction between trans-acting Gag 
polyprotein and cis-acting elements in the genomic RNA. The cis-elements are known as 
packaging signals (psi or Ψ) and have been mapped in the 5' leader region of unspliced 
genomic RNA in many retroviruses (Katz et al, 1986; Linial & Miller, 1990; Rein, 1994).   
The packaging signal of HIV-1 has been extensively studied. Deletion analyses 
have found that the most important packaging signal (Ψ core) of HIV-1 genomic RNA 
lies between the major splice donor site (SD) and the gag initiation codon in the leader 
region (Aldovini & Young, 1990; Clavel & Orenstein, 1990; Lever et al, 1989). In vitro 
studies have suggested that the HIV-1 packaging signal is composed of at least four stem 
loops located both upstream and downstream of SD (Berkowitz & Goff, 1994; Clever et 
al, 1995). Although the HIV-1 Ψ core is located downstream of SD in the leader region, 
other packaging signals have been characterized either upstream of SD (Kim et al, 1994) 
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or even outside the 5’ leader region (Berkowitz et al, 1995a). Thus, the full HIV-1 
packaging signal is a complex, compound structure.  
The HIV-2 packaging signal has been less extensively studied and conclusions 
about the exact location of the Ψ core have been more controversial (Garzino-Demo et al, 
1995; Griffin et al, 2001; McCann & Lever, 1997; Poeschla et al, 1998). Several studies 
demonstrated the importance of sequences located downstream of SD (Garzino-Demo et 
al, 1995; Poeschla et al, 1998).  However, other studies showed that deletion of a 28nt 
sequence located upstream of SD caused a severe packaging defect for HIV-2 genomic 
RNA packaging while mutation of sequences downstream of SD had mild effects on 
packaging (Griffin et al, 2001; McCann & Lever, 1997). The unusual localization of the 
HIV-2 Ψ core upstream of SD suggested that unlike HIV-1, the strongest HIV-2 
packaging signal is present in both unspliced and spliced viral RNAs (McCann & Lever, 
1997). In addition, a 10nt palindrome sequence called pal (5’-392GGAGUGCUCC401) was 
described within the 28nt Ψ core sequence, just upstream of the SL1 dimerization signal 
(Lanchy et al, 2003a) (Figure 16B). Mutations of the pal element revealed its 
involvement in RNA dimerization both in vitro and in vivo (Baig et al, 2007; L'Hernault 
et al, 2007; Lanchy et al, 2003a; Lanchy & Lodmell, 2007). 
Since the pal motif is present in the HIV-2 packaging signal and can interfere with 
HIV-2 leader RNA dimerization in vitro, its role during viral replication was investigated. 
Deletion and substitution studies indicated that pal is required for efficient genome 
packaging and viral replication (Lanchy & Lodmell, 2007). Reversion analysis of pal 
mutant viruses in long term culture suggested that the 3’ side of pal (GCUCC-3') interacts 
with a downstream sequence and forms an extension of SL1 called stem B that is 
 63 
required for viral replication and genomic encapsidation (Lanchy & Lodmell, 2007).  In 
parallel, an in vitro SELEX study found the 3' side of pal to be involved in the stem B 
structure that regulates SL1-mediated HIV-2 RNA dimerization in vitro (Baig et al, 
2007). Finally, mutations in the pal/SL1 region showed pal to be the most important 
determinant for genomic RNA packaging and dimerization (L'Hernault et al, 2007). 
These studies have clearly suggested a structural and functional role for the 3' side 
of pal in vitro and in vivo. To understand the role of the 5' side of pal, we used an in vivo 
randomization/selection methodology similar to one first employed by Berkhout and 
Klaver (Berkhout & Klaver, 1993) to study the role of the bulge and loop of the TAR 
element during viral replication in eukaryotic cells. Using this technique, we selected for 
replication-competent viruses from a population of viruses that were randomized in pal. 
We constructed a library of full-length HIV-2 proviral DNA genomes with random 
sequences in the 5’ side of pal and selected viable viruses after transfection and 
subsequent infection of permissive cells. Our sequencing data showed that 5’pal 
nucleotides of the selected viable (“winner”) viruses converged to the consensus 
sequence 5’-GGRGN.  Analysis of individual clones that diverged from this sequence 
showed replication defects and impaired RNA packaging, while sequences of the type 5’-
GGRGN restored these features. These data strongly support the hypothesis that pal is a 
critical packaging signal during the HIV-2 replication cycle.  
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 Figure 16. Schematic of the 5’ untranslated leader region of HIV-2 genomic RNA.  
A. The 5’ leader region of HIV-2 RNA is represented with boxes and numbers to indicate the landmark 
sequences with their names indicated above. TAR, poly A signal, PBS, ψ, SL1, SD, and gag represent the 
trans-activation region, the poly (A) signal domain, the primer binding site, the packaging signal, the stem 
loop 1, the major splice donor site, and the 5’ end of the Gag protein coding region, respectively. B. The 
secondary structure of Ψ-SL1 region (nucleotides 380-448) (Baig et al, 2007; Dirac et al, 2001; McCann & 
Lever, 1997). The pal element is a 10nt palindrome sequence (nts 392-401) within Ψ, located immediately 
upstream of SL1 and is represented by bold letters. Nucleotides 392-396 and 397-401 represent the 5’- and 
3’ sides of pal, respectively. The 3’ pal sequence is involved in a base-pairing interaction with a sequence 
downstream of SL1 and creates stem B. The 5’ side of pal is a purine rich motif upstream of 3’ pal 
pyrimidine-rich sequence. The 6-nt autocomplementary sequence essential for SL1-mediated dimerization 
in the apical loop of SL1 is outlined. C. Five nts at the 5’ side of pal (positions 392 to 396) were 
randomized in the insertion segment and inserted into the full-length proviral DNA as described in the text. 
The last five nts of pal (nts 397-401) were kept wild-type so as not to disrupt stem B.  
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3.3. Materials and Methods 
 
3.3.1. Construction of plasmids for generation 
of randomized proviral DNA libraries   
 
To rule out the chance of contamination by wild-type (wt) proviral DNA plasmid 
in the pal-randomized libraries, we used a parent plasmid called pSCR2, which harbors 
deleterious mutations in pal sequence as described previously (Lanchy & Lodmell, 2007) 
to construct our random library. pSCR2 was derived from modified pROD10 (a full-
length plasmid containing infectious HIV-2 DNA sequence) and remained non-infectious 
even after several months in culture (Lanchy & Lodmell, 2007).  
To create a vector for generating the randomized libraries, a derivative of pSCR2 
plasmid called pSCR2AleIΔ(396-2030) was constructed, in which a fragment 
encompassing nucleotides 396-2030 of the viral genome including part of the non-coding 
region, and most of the Gag coding region up to the XhoI site was deleted and a 
nucleotide was substituted (A394T) to introduce a unique restriction site (AleI) 
corresponding to nts 386-395. All nucleotide numbering in this study is referenced to the 
RNA sequence of HIV-2 (ROD isolate, GenBank M15390). The mutated vector sequence 
is as follows: 5’380ACAAACCACGACGGtG395//2030CTCGAG-3’, where AleI and XhoI 
sites are underlined and the small t indicates the changed nucleotide. 
The pSCR2AleIΔ(396-2030) was constructed as follows. A fragment containing 
the long terminal repeat and the sequence up to nt 395 with the A394T substitution along 
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with 6-nt subsequent sequence of XhoI site was amplified by using sense primer (M13 
Forward (-41) binding upstream of an unique AatII site;  
Table 4) and an antisense primer (asXhoI-AleI, containing the XhoI and AleI 
sites;  
Table 4). The amplified product was digested with AatII/XhoI and ligated into the 
pSCR2 plasmid vector missing the original AatII-XhoI fragment. The ligated product was 
transformed in E. coli DH5α cells, ampicillin resistant colonies were selected, followed 
by plasmid DNA purification.  
3.3.2. Generation of pal-randomized proviral 
DNA library  
 
To generate the proviral DNA library that is randomized at the 5’ side of pal (5nt 
RND pal), we used an In-Fusion (Clontech) in vitro DNA recombination protocol, which 
obviates the need of a DNA ligase step and combines the insert and vector due to the 
homologous regions at both 5’ and 3’ ends of insert and digested vector. We constructed 
our vector and randomized insert with these homologous regions by the use of long 
primers as per the manufacturer’s protocol.  
To create the vector for use in the In-Fusion reaction, the pSCR2AleIΔ (396-
2030) plasmid was digested with AleI and XhoI and purified by agarose gel 
electrophoresis followed by gel extraction (5PRIME) prior to combining with the 
randomized insert. 
To construct the randomized insert, a PCR product (nts 369-2050) was generated 
using a mutagenic sense primer (sPal-random-5;  
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Table 4) with degenerate nucleotides at positions 392-396 and an antisense primer 
(asROD2050;  
Table 4) and using pSCR2 as a template.  The PCR mixture contained 0.4 ng of 
pSCR2, 0.2 µM of the sense and antisense primers ( 
Table 4), dNTPs mix (0.2 mM), 1x Taq standard buffer, and 0.5 µl of Taq 
polymerase enzyme (New England Biolabs) in a final reaction volume of 50 µl. A 40 
cycle PCR protocol with a 55°C annealing temperature was used. The PCR product 
(randomized insert) was purified by agarose gel electrophoresis. 
The randomized insert was combined with the digested pSCR2AleIΔ(396-2030) 
vector at a 2:1 ratio and transferred to an In-Fusion reaction tube. The resulting 
recombined product was transformed into E. coli DH5α and DNA was extracted from 
bulk transformation reactions to obtain the randomized proviral DNA library. The 
degeneracy of pal region in the plasmids of this library was checked by sequencing 
(Table 5). Although there was a bias in oligonucleotide synthesis that favored the 
incorporation of purines somewhat over pyrimidines, each nucleotide was sufficiently 
represented to ensure adequate mutagenesis at each position in the reconstructed proviral 
DNA library. 
 
3.3.3. Cell culture and transfections of 5nt RND 
pal library 
 
COS-7 cells were maintained in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal calf serum, penicillin, and streptomycin (Invitrogen). COS-
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7 cells were transfected with randomized library (5nt RND pal plasmids) using a Trans-
IT-COS transfection kit (Mirus). Two days post-transfection, the cells and media were 
harvested and the presence of virus in the medium was monitored by p27-specific 
enzyme-linked immunosorbent assay (SIV p27 ELISA; Zeptometrix). 
 
3.3.4. Cell culture and infections of RND viruses 
 
C8166 cells (NIH AIDS reagent 404) were maintained in Roswell Park Memorial 
Institute (RPMI) 1640 medium supplemented with 10% fetal calf serum, penicillin, 
streptomycin and glutamine (Invitrogen). The media of transfected cells containing 5nt-
pal viruses was filtered through 0.22-µm-pore size filters. Viruses were collected from 
the media by centrifugation for 2 hours at 4°C and 8500 rpm (10,015 rcf). The resulting 
viral pellet was resuspended in 2.0 ml RPMI. Subsequently, 1.5 ml was used for infection 
in 105 C8166 cells. This 1.5 ml corresponded to 250ng of HIV-2 CAp27 for 5 nt RND pal 
viruses, as determined by ELISA.  Aliquot of 0.5 ml was saved at -80°C for RNA 
extraction. After 12 h at 37°C, cells were washed and resuspended in fresh RPMI 
medium-fetal calf serum. Every 7-10 days, the viruses produced in the media were 
filtered through 0.22-µm syringe filters and were used to reinfect fresh uninfected 105 
C8166 cells.  
Virus propagation for 5nt RND pal library was monitored by quantifying the 
concentration of CAp27 protein (determined by ELISA; Zeptometrix) in the medium at 
different days post infection (d.p.i.) (data not shown). In addition, aliquots of medium 
 69 
containing filtered viruses were saved at 4, 9, 15, and 41 d.p.i. for RNA isolation and 
analysis.  
 
3.3.5. RNA isolation and analysis of non-
selected and selected sequences from 5nt RND pal 
library  
 
The total COS-7 intracellular vRNA and fractions of COS-7 and C8166 (19 and 
41 d.p.i.) extracellular vRNAs from 5nt RND pal viruses were purified using a Stratagene 
Absolutely RNA microprep kit. To pellet the virus particles, saved aliquots were 
centrifuged for 2 hours at 4°C and 15,000 rpm (21,882 rcf). Purified RNAs were used for 
reverse transcription-PCR (AccuScript high-fidelity RT-PCR system; Stratagene) using 
sBamT7R and asEco561 primers (Table 4). An aliquot of each RT-PCR reaction was 
sequenced directly as a pool while the rest of the reaction was digested with 
BamHI/EcoRI to clone individual sequences. The digested products were ligated with 
BamHI and EcoRI sites of pUC18 vector and transformed in competent DH5α E. coli. 
Individual DNA plasmids were sequenced to examine the in vivo selection of the viable 
sequences and for further characterization.  
 
3.3.6. Construction of individual plasmids with 
winner and loser sequences in the 5’ pal region 
 
To construct full-length plasmids with the selected and non-selected sequences in 
the 5’ pal region, we employed the above-described In-Fusion strategy by using the same 
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vector but with different inserts that contained desired mutations in the 5’ pal region. The 
inserts with non-selected “loser” (SM2 and TTB-16) and selected “winner” (TTB-78) 
sequences were constructed by using sense primers (sPal-SM2, sPal-TTB-16 and sPal-
random-2, respectively (Table 4) and the antisense primer asROD2050 (Table 4) in 
separate PCR reactions. Since the wild-type (wt) sequence was one of the selected 
sequences (TTB-61 & 76, Table 7A & B), we used the modified pROD10 plasmid 
(Lanchy & Lodmell, 2007). 
   
M13 Forward (-41) CGC CAG GGT TTT CCC AGT CAC GAC 
asXhoI-AleI AAC TCG AGC ACC GTC GTG GTT TGT TCC TG 
sPal-random-5 GGG CGG CAG GAA CAA ACC ACG ACN NNN NGC TCC TAG AAA GGC 
GCG GGC CGA GG 
asROD2050 GGT GTC TCC CCC TGC TC 
sBamT7R TAG GAT CCT AAT ACG ACT CAC TAT AGG TCG CTC TGC GGA GAG 
asEco561 AAG AAT TCA GTT TCT CGC GCC CAT CTC CC 
sPal-SM2 GGG CGG CAG GAA CAA ACC ACG ACC CTC TGC TCC TAG AAA GGC 
GCG G                     
sPal-TTB-16 GGG CGG CAG GAA CAA ACC ACG ACA CCT GGC TCC TAG AAA GGC 
GCG G 
 
sPal-random-2 GGG CGG CAG GAA CAA ACC ACG ACG GNG NGC TCC TAG AAA GGC 
GCG G 
 
 
Table 4. Oligonucleotides used in chapter 3.  
Sequences are shown in the 5’ to 3’ direction. 
 
3.3.7. Transfections of non-selected and selected 
individual plasmids  
 
Full-length plasmids with loser and winner sequences were transfected in COS-7 
cells individually as described above. 
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3.3.8. Replication assay of non-selected and 
selected clones  
 
200µl of medium from transfected COS-7 cells containing 0.6ng of HIV-2 p27 
capsid protein, as determined by ELISA, was used to infect 105 C8166 cells. After 12 h, 
cells were washed twice and resuspended in fresh RPMI medium-fetal calf serum. Viral 
replication was followed for up to 16 days for the selected and non-selected individuals 
by quantifying the concentration of CAp27 protein (determined by ELISA; Zeptometrix) 
in the medium at d.p.i. (different days post infection). 
 
3.3.9. Single round infectivity assay of non-
selected and selected individuals 
 
The infectivity of viruses in the medium of COS-7 cells was quantified using 
CMMT-CD4-LTR-βgal indicator cells. This cell line expresses the CD4 receptor and 
contains a β-galactosidase gene fused to the HIV long terminal repeat, thus detecting 
synthesis of the transactivating (Tat) protein after productive infection of the cells by the 
input virus (Chackerian et al, 1995). After two days of culture post-infection, the cells 
were stained for β-galactosidase activity, and the blue infected cells were counted.  The 
numbers were normalized first to the amounts of input viruses, as determined by ELISA, 
and second to the level of infection by wt virus to give the infectivities of viruses relative 
to wt. 
 72 
 
3.3.10. RNA isolation and RNase protection 
assay for non-selected and selected individuals  
 
The COS-7 intracellular vRNAs were purified using a Stratagene Absolutely 
RNA miniprep kit. For extracellular vRNAs, a fraction (1ml) of the medium was 
centrifuged for 2 hours at 4°C and 15,000 rpm (21,882 rcf) to pellet the viral particles, 
followed by lysis and RNA purification.  Purified RNAs were used separately for RNase 
protection assays (RPA III; Ambion), as described by the manufacturer. The RNase 
protection assay was carried out using a 32P-labeled antisense RNA probe complementary 
to positions 401-562 of the HIV-2 RNA ROD isolate as described in (Lanchy & Lodmell, 
2007). The antisense region was cloned into the Promega pGEM 7Zf(+) vector 
(Novagen) so that the T7 transcript had approximately 45 nucleotides of vector at its 5’ 
end. The non-HIV-2 tail of the probe was used as a marker of the RNase digestion 
efficiency during the experiment.  
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3.4. Results 
3.4.1. Generation and selection of 5nt RND pal 
library 
 
We previously showed that a 10nt palindrome (pal) sequence (5’-
GGAGUGCUCC-3’), located at the 3’ end of Ψ was important for regulating SL1- 
mediated HIV-2 RNA dimerization in vitro (Lanchy et al, 2003a).  Using SELEX 
methodology, we showed that this regulation is mediated by the formation of an extended 
SL1 structure created by the interaction of the 3’ side of pal (GCUCC-3’) with an 
immediate downstream sequence of SL1 (Baig et al, 2007). Moreover, formation of the 
extended SL1 structure is necessary during viral replication (Lanchy & Lodmell, 2007). 
Although both studies demonstrated the importance of the 3’ side of pal, the role of the 5’ 
side of pal (5’-GGAGU) was not well understood. Therefore, we have investigated the 
role of 5’ side of pal in HIV-2 replication, by subjecting this region to randomization and 
subsequent in vivo selection.  
The in vivo SELEX method starts with the generation of a pool of viral genomes 
containing many possible mutations at randomized sequences in a particular region 
(Berkhout & Klaver, 1993). We synthesized a pool of HIV-2 proviral DNA genomes 
with five randomized nucleotides of pal at positions 392-396 so that the DNA library 
harbored 392NNNNN396 sequence (where N has an equal probability of being A, C, G, T; 
Figure 16C). 
The recombinagenic method used for the generation of the 5nt RND pal library is 
detailed in the Materials and Methods.  Briefly, a pSCR2AleIΔ(396-2030) vector and an 
insert (randomized at 5’ pal) were assembled in an In-Fusion (Clontech) recombinagenic 
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reaction by virtue of the engineered homologous regions at their 5’ and 3’ ends. The 
recombined product was transformed in E. coli to produce a library of full-length HIV-2 
proviral DNA plasmids with up to 1024 (i.e. 45) possible sequence variations at the 5’ 
side of pal.  To verify degeneracy of the library, a fraction of the bacteria transformed 
with the recombinagenic PCR products were counted and their plasmids sequenced. 
Sequencing of 38 individual clones (Table 5) revealed the presence of all four nucleotides 
at each position, although some purine bias in the synthesized oligonucleotides was 
noted. The diversity of the library allowed adequate interrogation of each position in the 
392-396 pal region. 
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RND proviral DNA library 
 392 393 394 395 396 
Clone 
WT G G C G A 
TTB83 G G C G A 
TTB84 A T G A A 
TTB85 C G A G A 
TTB86 T G T T A 
TTB87 C A T G T 
TTB88 G T A G A 
TTB89 T A C A C 
TTB90 G A C A G 
TTB91 C C A G T 
TTB92 G A C A T 
TTB93 G A T G A 
TTB94 G T G A G 
TTB95 G G A A C 
TTB96 A A A A G 
TTB97 G G G G A 
TTB98 G A T C A 
TTB99 G A G A A 
TTB100 G C G T A 
TTB101 G G T A G 
TTB102 A A G G A 
TTB103 G A A A A 
TTB104 T A A A T 
TTB105 A C G T C 
TTB106 G T A T C 
TTB107 G G A G G 
TTB108 T A G C G 
TTB109 G A T C G 
TTB110 A G T G G 
TTB111 A A A A G 
TTB112 G A G A A 
TTB113 G G A T C 
TTB114 A C C A G 
TTB115 C G C G T 
TTB116 G T G A G 
TTB117 A A G A T 
TTB118 G A T G A 
TTB119 G C A G A 
TTB120 T A G G A 
Table 5. Sequences of individual clones in the 5nt randomized proviral DNA library used for COS-7 
cells transfection. 
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To initiate selection, the purified plasmid DNA library was first transfected into 
COS-7 cells to produce the library of 5nt RND pal viruses.  To monitor the sequence 
diversity and to confirm that no individual sequence was dominating in the 5nt RND pal 
library at the transfection stage, we analyzed the leader sequences of intracellular and 
packaged genomic RNAs after RT-PCR. Sequence analysis of the RT-PCR product as a 
pool showed that COS-7 intracellular and packaged vRNAs contained random sequences 
at the 5’ side of pal (data not shown). In addition, RT-PCR products were subcloned to 
obtain the sequence of individual clones. Sequence analysis of 25 and 21 individual 
clones from COS-7 intracellular and packaged (extracellular) vRNAs, respectively, 
confirmed that no single sequence was predominating in the library at this stage (Table 
6A and B). However, a bias toward purines at nts 392-396 was already evident in the 
viral RNAs that were packaged and exported as viral particles into the media of the 
transfected COS-7 cells.  
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(Table 6A)        (Table 6B) 
 COS-7: intracellular vRNA 
 nt number 
392 393 394 395 396  Clone 
WT G G A G U  
TTB-1 A G C U U  
TTB-2  A A U U U  
TTB-3  U C U A A  
TTB-4 A G G A A  
TTB-5 G G G A G  
TTB-6 C A G G G  
TTB-7 G G C C G  
TTB-8 A U G C U  
TTB-9 A A G U C  
TTB-10 A A A A A  
TTB-11 A G G A A  
TTB-12 A G A A C  
TTB-13 U A A C G  
TTB-14 G G C A G  
TTB-15 U A G G U  
TTB-16 A C C U G  
TTB-17 U U A G U  
TTB-18 G U G G C  
TTB-19 G U U U U  
TTB-20 A A G G C  
TTB-21 G G C A G  
TTB-22 A C G G G  
TTB-23 A C U G G  
TTB-24 U A C A G  
TTB-25 G G A A G  
 
Table 6. Sequence of 5nt RND pal virus library inside and outside of COS-7 cells after transfection. 
Viral RNAs extracted from COS-7 cells (intracellular) and media (extracellular) were subjected to RT-
PCR, cloning, and sequencing as described in Materials and Methods. TTB-1 to 25 represent RNAs that 
were expressed intracellularly and may or may not be packageable.  TTB-26 to 46 represent those RNAs 
that were exported as viral particles into the media of COS-7 cells and thus were at least marginally 
competent for packaging. The name of the individual clone (TTB-16) tested for infectivity and packaging is 
in bold text.  
 
COS-7: extracellular vRNA 
 nt number 
392 393 394 395 396  Clone 
WT G G A G U  
TTB-26 G U G A G  
TTB-27 A G A A C  
TTB-28 G G A A A  
TTB-29 A A G G G  
TTB-30 G U A A G  
TTB-31 C A U A G  
TTB-32 A A G G A  
TTB-33 G G G G G  
TTB-34 U U A A C  
TTB-35 G G G U A  
TTB-36 G A A G U  
TTB-37 G G G U U  
TTB-38 A G A G G  
TTB-39 A G G A U  
TTB-40 G U A G G  
TTB-41 G C U U U  
TTB-42 G G G G C  
TTB-43 G G C U G  
TTB-44 G G A A A  
TTB-45 G G G U G  
TTB-46 A U G C G  
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To study the selection of 5’ pal sequences during viral replication and infection 
cycles, media from COS-7 transfected cells was used to infect permissive C8166 cells. 
Virus production was detected within a few days of infection in the media of C8166 cells 
by p27 capsid ELISA. Therefore, we harvested virus at 4 days post-infection, followed by 
vRNA purification, RT-PCR, and sequencing. Sequence analysis of the RT-PCR 
products showed selection at 4 d.p.i. for Gs at positions 392 and 393 (data not shown). 
Sequencing viral RNA from 9 and 15 d.p.i. showed that the selection was complete at 
position 392, and nearly complete for positions 393 & 395 (Table 7A). By 41 d.p.i., 
selection was obvious for the entire random region: viral RNAs had converged on the 
consensus sequence GGRGN (Table 7B), where N represents T, G or A at position 396 
(no Cs were observed). The absence of C396 in the recovered viral RNAs may have been 
a result of negative selection, sampling artifact, or because of the relative under 
representation of C in the library. C396 viruses were present as packageable viruses in 
the post-transfection sampling (Table 6), so it appears that they are viable but are likely 
overrun during longer infection schemes (Table 6).  
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 (Table 7A)      (Table 7B 
C8166: 9 d.p.i. 
  nt number 
392 393 394 395 396  Clone 
WT G G A G U  
TTB-47-48 G G A A A  
TTB-49-50 G G A G G  
TTB-51-52 G G G G G  
TTB-53-54 G G A G A  
TTB-55 G G G U A  
TTB-56 G G G C G  
TTB-57-58 G G G C A  
TTB-59 G G U A G  
TTB-60 G G U A A  
TTB-61 G G A G U  
TTB-62-65 G A G G G  
 
Table 7. RNA sequences of those viruses that were selected after several rounds of infection in C8166 
cells.  
Viral RNAs extracted from viruses at 9 d.p.i.  (Table A) and 41 d.p.i.  (Table B) d.p.i. were subjected to 
RT-PCR and cloning as described in Materials and Methods. TTB-47 to 65 (9 d.p.i.) and TTB-66 to 82 (41 
d.p.i.) clones were sequenced in the 5’ pal region. Those sequences which appeared two or more times are 
shown in only one row (e.g., TTB-66-71). The name of the individual clones (TTB-76 (wt) and TTB-78) 
tested for infectivity and packaging are in bold text. 
 
3.4.2. A purine rich sequence at the 5’ Side of 
pal is important for viral replication 
 
In wt HIV-2 the 5’ side of pal contains a purine rich sequence (5’-GGAGU) and 
the in vivo 5nt RND pal selection demonstrated the importance of the 5’-GGRGN motif. 
We therefore compared viral replication properties of pyrimidine rich non-consensus and 
purine rich consensus clonal viruses. The pyrimidine rich clones used in this experiment 
were TTB-16, a non-surviving intracellular COS-7 sequence (5’-accug, where lower case 
C8166: 41 d.p.i. 
nt number 
392 393 394 395 396  Clone 
WT G G A G U  
TTB-66-71 G G A G A  
TTB-72-75 G G A G G  
TTB-76 G G A G U  
TTB-77 G G A A G  
TTB-78-80 G G G G U  
TTB-81 G G G U A  
TTB-82 G G G U G  
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letters signify nucleotides different from the wt sequence; Table 6A) and SM2 (5’-cuccU; 
Figure 17), a replication-deficient 5’ pal pyrimidine rich mutant previously described by 
Lever and co-workers (L'Hernault et al, 2007). The winner viruses were the purine rich 
clones TTB-76 (5’-GGAGU (wt sequence); Table 7B) and TTB-78 (GGgGU; Table 7B). 
Duplicate samples of these four DNA constructs were transfected into COS-7 
cells. Forty-eight hours after transfection, viruses were harvested and used to infect 
C8166 cells with an equivalent amount of p27 capsid, as measured by ELISA. Virus 
spread was followed by measuring p27 capsid in the C8166 media by ELISA. Infections 
with purine rich TTB-76 and TTB-78 viruses led to robust virus production, whereas 
those with pyrimidine rich SM2 and TTB-16 sequences showed low or no virus 
production for up to 16 d.p.i. (Figure 17). These results support our hypothesis that the 
purine rich 5’-GGRGN in the 5’ side of pal is essential for viral replication. 
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Figure 17. Mutant HIV-2 viruses harboring pyrimidines at the 5’ side of pal exhibit replication 
defects.  
(Top) Sequence at 5’ side of pal (nts 392-396) in wt and mutant individuals used in this experiment. TTB-
76 (wt) and TTB-78 contain the pal sequence derived from viral clones that were winners after extended 
serial passage (Table 7B). TTB-16 represents a sequence that was observed intracellularly after transfection 
but that did not survive during serial infections in C8166 cells (Table 6A). SM2 is a packaging-deficient 
mutant previously characterized by the Lever group that was used here for comparison with our own clones 
containing pyrimidines in the 5’ side of pal (L'Hernault et al, 2007). The mutated residues are represented 
by lowercase letters. (Bottom) Replication kinetics of wt (closed squares), TTB-78 (open squares), TTB-16 
(open circles) and SM2 (open triangles) viruses in C8166 cells. Equal amounts of viral particles  (0.6ng of 
p27 capsid, as determined by ELISA), produced in the media by transfection of DNA plasmids in COS-7 
cells were used to infect permissive C8166 cells. Virus production from these cells was assayed for the 
production of p27 capsid at intervals post infection. Results are based on infections of separate plates of 
permissive cells using virus harvested from two independent transfections for each clone. Error bars  
represent one standard deviation for a representative experiment.  
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3.4.3. A purine rich sequence (GGRGN) at the 
5’side of pal is important for genomic RNA 
packaging  
 
With the aim of further identifying which steps of HIV-2 viral replication in 
C8166 cells were affected by non-wt substitutions in the 5’ side of pal, viruses produced 
from transfection of COS-7 cells with SM2, TTB-16, TTB-76 (wt), and TTB-78 proviral 
DNAs were assessed for infectivity/entry in CMMT-CD4-LTR-βgal indicator cells. The 
infectivity of these cells can be examined by the detection of a Tat-driven reporter gene 
whose expression is dependent on HIV entry into the cell (Chackerian et al, 1995). As 
observed in C8166 cells, SM2 and TTB-16 also showed a lower level of infectivity in 
CMMT-CD4-LTR-βgal indicator cells as compared to TTB-76 and TTB-78 (Figure 
18A).  
Since the packaging signals in retroviruses contain purine rich motifs (Berkowitz 
et al, 1996) and the 5’ pal element is both purine rich and located within the HIV-2 
packaging signal (Griffin et al, 2001; Lanchy & Lodmell, 2007), we investigated the role 
of 5’ side of pal as an important RNA packaging element. We assessed and compared the 
packaging of RNAs containing consensus 5’ pal sequence (TTB-76 (wt) and TTB-78) 
with packaging of RNAs containing the non-consensus 5’ pal sequence (TTB-16 and 
SM2). We performed RNase protection assays (RPA) on TTB-16, SM2, TTB-76 (wt) and 
TTB-78 RNAs extracted from the cytoplasm of COS-7 transfected cells and from the 
COS-7-produced viruses. As seen in (Figure 18B), neither non-wt consensus nor the non-
consensus sequences affected the level of genomic RNA in the cytoplasm of the 
transfected cells relative to wt.  However, virions produced by these transfected cells 
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showed that the level of genomic RNA packaging was high in the consensus 5nt RND pal 
viruses (TTB-76 and TTB-78) but was reduced in the pyrimidine rich 5’ pal viruses 
(TTB-16 and SM2) (10-15%) as compared wt (Figure 18C). Further, to ensure that 
mutations in 5’ side of pal did not affect viral gene expression, we analyzed viral proteins 
from intra- and extracellular COS-7 fractions using western blot analysis. Our data show 
that mutation of 5’ pal region does not affect viral gene expression (Figure 19).  These 
data taken together suggest that the replication defect seen in viruses with a pyrimidine-
rich 5’ pal sequence is due to a packaging defect. 
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Figure 18. HIV-2 virus infectivity and genomic RNA packaging are decreased by the presence of 
pyrimidines at the 5’ side of pal. 
A. Single-round infectivity assay for wt and 5’ pal mutant viruses isolated from transfected COS-7 cells 
using CMMT-CD4-LTR-βgal indicator cells (see Materials and Methods). Sequences of wt and mutant 5’ 
pal for the viruses used in this experiment are shown at the top panel of (Figure 17). Virus generated by 
transfection of COS-7 cells was quantified by p27 ELISA and used to infect the indicator cells. Forty-eight 
hours post-infection, cells were stained to visualize cellular β-gal expression.  Infectivity was normalized to 
the infectivity of wt virus, set at 100%. Infectivity was measured in two independent experiments and 
results are shown with error bars that represent the standard deviation. B. Quantification of full-length 
genomic RNA in the cytoplasmic fraction of COS-7 cells transfected with wt and 5’ pal mutants using an 
RNase protection assay. Cells were harvested from two independent transfections of wt and 5’ pal mutants. 
Three microgram of cytoplasmic RNA was probed with  2x106 cpm of labeled riboprobe. Lanes 1, 2, 3 and 
4 represent amounts of genomic RNAs from TTB-76 (wt) (5’-GGAGU), SM2 (5’-ccucU; (L'Hernault et al, 
2007)), TTB-16 (5’-accug) and TTB-78 (5’-GGgGU) viruses, respectively. Lanes 5 represents yeast RNA 
used as a non-specific target RNA control, incubated without RNases. C. Quantification of full-length 
genomic RNA in wt and 5’ pal mutant viruses using an RNase protection assay. Viruses were harvested 
from the media of transfected COS-7 cells from two independent transfections of wt and 5’ pal mutants. 
First, the extracted RNAs form these viruses were normalized to the amount of viral particles (p27 capsid 
as determined by ELISA) and an equivalent amount of these RNAs were probed with 5x105 cpm of labeled 
riboprobe.  Lanes 1, 2, 3 and 4 represent amounts of genomic RNAs from COS-7 cells transfected with 
TTB-76 (wt) (5’-GGAGU) and 5’ pal mutants (SM2 (5’-ccucU; (L'Hernault et al, 2007)), TTB-16 (5’-
accug) and TTB-78 (5’-GGgGU)), respectively. Lanes 5 & 6 represent yeast RNA used as a non-specific 
target RNA control, incubated with or without RNases, respectively. D. Schematic representation of the 
radioactive probe used in this experiment and a predicted protected fragment corresponding to the 
unspliced leader region. 
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Figure 19. Mutations within the 5’ side of pal do not affect viral gene expression.  
A. Western blot analysis of COS-7 extracellular viral proteins. Protein samples from equivalent number of 
virions, as determined by p27 capsid ELISA were loaded in each lane. HIV-2 proteins were detected with 
human serum from an HIV-2 infected patient. Lanes 1, 2, 3 and 4 represent proteins from TTB-76 (wt) (5’-
GGAGU), SM2 (5’-ccucU; (L'Hernault et al, 2007)), TTB-16 (5’-accug) and TTB-78 (5’-GGgGU) viruses, 
respectively. B. Western blot analysis of COS-7 intracellular viral proteins. Wild type and 5’ pal mutants 
were tested for viral gene expression inside the COS-7 cells.  Equal amount of cell lysate was loaded in 
each lane. HIV-2 proteins were detected with human serum from an HIV-2 infected patient (HIV-2 
Reference sera, NIH AIDS Research & Reference Reagent Program 7G 1337 & 6F D150). Lanes 1, 2, 3 
and 4 represent proteins from COS-7 cells transfected with TTB-76 (wt) (5’-GGAGU) and 5’ pal mutants 
(SM2 (5’-ccucU; (L'Hernault et al, 2007)), TTB-16 (5’-accug) and TTB-78 (5’-GGgGU)), respectively.  
The positions of the detected proteins with their molecular size are shown. 
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3.5. Discussion 
 
Retroviral packaging occurs by means of interactions between the nucleocapsid 
(NC) domain of the Gag polyprotein and the packaging signal (Ψ) of unspliced genomic 
RNA (see review; D'Souza & Summers, 2005). For HIV-2, Ψ is located upstream of the 
major splice donor site, SD, in the 5’ untranslated leader region of genomic RNA (Figure 
16). In this study, we investigated the role of pal, a 10nt palindrome sequence (5’-
392GGAGUGCUCC401) situated within Ψ (Figure 16). The 3’ side of pal (GCUCC-3’) 
contributes to the formation of stem B, an extension of SL1 involved in the packaging of 
HIV-2 RNA, although the function of the 5’ side of pal (5’-GGAGU) was less well 
defined (Lanchy & Lodmell, 2007).  To ascertain the sequence constraints and role(s) of 
pal, we have used a randomization/in vivo selection methodology to investigate 
sequences in pal that are important for packaging and replication. In vivo selection 
approaches have been used previously to isolate replication-competent viruses from a 
complex population of viruses during replication in eukaryotic cells (Berkhout & Klaver, 
1993; Doria-Rose & Vogt, 1998; Morris et al, 2002). This method allows for mutational 
analysis of an ensemble of variant viruses without making a priori assumptions that 
might influence the choice of mutations. In contrast to the methods used before, here we 
used a recombinagenic method that enables high efficiency incorporation of the 
randomized region into the proviral DNA vector. We were able to select from among a 
large number of mutant viral sequences only those that were viable.  
After in vivo selection of the RND pal viral libraries, sequence analysis showed 
that nucleotide variation was not well tolerated at positions 392, 393 and 395 of the 5’ pal 
region during viral replication, and G was strongly selected at each of these positions. For 
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position 394, the dominance of A among the viable winner viruses also reflects its 
importance for viral replication. This finding is supported by phylogenetic analysis 
(Figure 20B) and our previous phenotypic reversion study in which mutant pal viruses 
harboring an A394G substitution reverted back to A (Lanchy & Lodmell, 2007). Here, in 
the 5nt RND pal selection, a consensus sequence (5’-GGRG) emerged in all viruses 
surviving the competition after several passages. We interpret this to mean that the 5’-
GGRG sequence is essential for optimal HIV-2 replication. In support of this, two non-
selected loser viruses with non-consensus pyrimidine-rich sequences were deficient in 
infectivity and replication (Figure 17).  
Compared to the strong selective pressure seen for positions 392-395, there were 
no obvious sequence constraints at position 396, except that we did not observe any C’s 
at this position in the final pool. The lack of Cs at 396 may indicate that viruses with 
C396 are somewhat impaired and are successfully outcompeted in this assay, or may 
reflect a sampling artifact, since we have observed in previous studies that mutant viruses 
harboring A or C at position 396 replicated like wt during short time course infections (J.-
M.L., unpublished).  It should be noted that position 396 exhibits a lower degree of 
phylogenetic conservation than adjacent residues among HIV-2/SIV isolates (Leitner, 
2005).  
On the basis of previous (L'Hernault et al, 2007; Lanchy & Lodmell, 2007) and 
the present work, we propose that the 5’ pal region comprises an essential component of 
the core packaging signal of HIV-2 RNA. First, as described above, winning viruses 
derived from the in vivo selection shared a consensus 5’-GGRG sequence (Table 7B).  
Second, this region is highly conserved among different strains of HIV-2 and SIV, where 
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37 of 37 published sequences show the 5’-GGAG sequence at this location (Figure 20B 
and (Leitner, 2005)). Third, packaging was strongly diminished in mutant viruses 
harboring sequences other than the 5’-GGRG sequence (Figure 18B and (L'Hernault et al, 
2007)).  
Several studies have demonstrated that the interaction between RNA and the 
packaging proteins Gag/NC is enhanced by the presence of unpaired G residues in the 
target RNA (De Guzman et al, 1998; Paoletti et al, 2002; South & Summers, 1993). In 
this study, secondary structure predictions of winner sequences suggest that, like wt, the 
5’-GGRG sequence is unpaired (compare Figure 20A and C), while among the loser 
viruses the 5’ side of pal was predicted to engage in stable base pairing with sequences 
downstream of SL1 (Figure 20D and E). Because of the similarities with known Gag/NC 
binding preferences (De Guzman et al, 1998; Fisher et al, 1998; L'Hernault et al, 2007; 
Lanchy & Lodmell, 2007; Paoletti et al, 2002), the 5’-GGRG consensus is likely to be an 
essential element for Gag/NC recognition and binding. 
In addition to its probable importance for Gag/NC binding, the Ψ-SL1 region of 
HIV-2 RNA adopts a specific conformation (at least transiently) during replication that is 
essential for efficient packaging. This conformation involves base pairing between the 3’ 
side of pal and sequence downstream of SL1 that results in the formation of stem B 
(Figure 16B; Figure 18C). Mutations disrupting stem B negatively affect RNA packaging 
(Baig et al, 2007; Griffin et al, 2001; Lanchy & Lodmell, 2007; McCann & Lever, 1997).  
Our present selection and RNA folding results raise the possibility that RNAs of TTB-16 
and SM2 were packaging deficient due to the increased stability of extended SL1. ΔG 
values for TTB-16 and SM2 SL1 RNA structures were -9.9 and -11.7 kcal/mol, 
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respectively, while wt and winner RNA sequences folded with a predicted ΔG value of -
8.3 kcal/mol.  Hyperstabilization of stem B may lead to a less favorable interaction of NC 
with this region (Kerwood et al, 2001) or to the sequestration of normally unpaired G 
residues that may be critical NC binding determinants (De Guzman et al, 1998; Fisher et 
al, 1998; Paoletti et al, 2002). 
Analysis of the predicted extended SL1 structures highlighted the presence of 
additional conserved 5’-GGAG sequences located downstream of stem B. In particular, 
packaging models presented by Summers and coworkers suggest that Gag/NC binds 
poorly to RNAs in which NC-binding elements are sequestered by base-pairing 
interactions with other regions (D'Souza & Summers, 2004; Dey et al, 2005). We suggest 
that the downstream 5’-GGAG sequence(s), could be a target for NC binding and 
cooperate with the 5’ GGRG motif to mediate packaging of HIV-2 RNA. This might 
explain why TTB-16 and SM2, in which the second 5’-GGAG was sequestered in an 
extended stem B (Figure 20D and E), were packaging-impaired (Figure 18C). 
On a technical note, we found that the use of the recombinagenic method 
provided a more efficient route to generate the randomized proviral DNA than traditional 
ligation protocols.  In vivo selection has been used to characterize important viral RNA 
signals previously, but difficulty in generating the library of randomized proviral DNA 
limited the number of sequences that could be simultaneously examined (T.T.B & J.-
M.L., unpublished and (Berkhout & Klaver, 1993; Doria-Rose & Vogt, 1998)).  This 
enhanced synthesis of randomized proviral DNA allows a larger degenerate segment to 
be tested.   
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A growing body of evidence points to the importance of the pal element within 
the HIV-2 core packaging signal (Griffin et al, 2001; L'Hernault et al, 2007; Lanchy & 
Lodmell, 2007; McCann & Lever, 1997).  The palindromic nature of this element has 
been enigmatic, but the current study demonstrates that pal is really composed of two 
complementary motifs, one that is required to be single stranded and a likely target for 
protein recognition, and the other that is crucial for an RNA-RNA interaction to form 
stem B. Because the major packaging signal (Ψ) in HIV-2 RNA is located upstream of 
SD, and is thus present in both spliced and unspliced RNA species (Figure 16), it is 
remarkable that only unspliced RNA is packaged. To gain further insights into the 
mechanism of HIV-2 packaging and RNA selectivity, it will be interesting to investigate 
the binding affinities of packaging proteins Gag/NC for spliced and unspliced RNA 
constructs. These experiments are underway in our laboratory. 
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Figure 20. Predicted secondary structures of selected (winner) and non-selected (loser) RNAs.  
A. Secondary structure model of pal-SL1 domain in HIV-2 ROD isolate (GenBank accession number 
M15390 (Baig et al, 2007; Lanchy & Lodmell, 2007)) as predicted by Mfold (Zuker, 2003). Stem B 
represents the interaction between 5’-GCUCC of pal and GGAGC-3’ sequence just downstream of SL1. B. 
& C. Stem B structure in HIV-2/ SIV strains (Leitner, 2005) and in the selected (winner) sequences derived 
from serial passage of the 5nt RND library is indicated. The stem B structure was predicted using two-state 
hybridization model in the DINAMelt server (http://www.bioinfo.rpi.edu/applications/hybrid/twostate.php) 
using standard parameters (RNA at 370C, [Na+]= 1M, [Mg2+]= 0M and [strand]= 0.00001M (Markham & 
Zuker, 2005). The consensus purine rich motif and the proportion of bases at position 396 in HIV-2/SIV 
strains and the winner viruses is shown to the left. D & E. The GGAG sequence at 3’ end of stem B in 
TTB-16 and SM2 is sequestered by base pairing with pyrimidines at the 5’ end of pal and potentially makes 
stem B significantly more stable. The nts different from the wt sequence are shown with lowercase letters. 
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Chapter 4: Human immunodeficiency virus 
type 2 Gag protein binds to a GGAG motif in 
the packaging signal of HIV-2 RNA  
 
 
This chapter consists of experiments done by the author of this dissertation. 
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4.1. Abstract 
 
A GGAG motif in the packaging signal at the 5’ end of HIV-2 genomic RNA has 
been found to be an essential element for packaging in vivo. Here we report studies aimed 
at characterizing this sequence as a binding element for Gag protein and for the NC 
domain of the Gag protein in vitro. The NC domain of Gag is known for its ability to 
bind to RNA packaging signals in vivo. Thus, the HIV-2 Gag and NC proteins were 
expressed and purified as C-terminal His-tag fusion proteins in order to use them in the 
binding studies with HIV-2 leader RNAs containing wt (GGAG) or non-wt (ACCU) 
sequences in the packaging signal. The gel shift assays revealed that NC protein binds 
identically with both RNAs, whereas the Gag protein binds specifically to HIV-2 RNA 
containing a GGAG sequence rather than RNA containing an ACCU sequence. These 
data suggest the binding of Gag to the GGAG sequence of packaging signal and playing 
an important role in mediating HIV-2 RNA packaging in vivo.  
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4.2. Introduction 
 
During the HIV packaging process, the precise targeting of full-length genomic 
RNA into virion particles is facilitated by specific interactions between cis-acting 
sequences, or packaging signals, in full-length genomic RNA and trans-acting regions in 
the Gag polyprotein (see reviews; D'Souza & Summers, 2005; Lever, 2007; Linial & 
Miller, 1990; Russell et al, 2004). In HIV-1, the packaging signals have been mapped to 
motifs located downstream and upstream of the SD site in the 5’ side of genomic RNA 
(Russell et al, 2004). In HIV-2, the packaging signal, comprised at least in large part of a 
28-nt long sequence, is located upstream of the SD site (Griffin et al, 2001). In a study 
aimed at further characterizing the packaging signal, a 10-nt pal sequence located within 
this packaging signal was identified as critical for HIV-2 genomic RNA packaging by 
forming an essential RNA structure (Lanchy & Lodmell, 2007). Further, the 5’ side of pal 
was shown to be essential for the HIV-2 packaging process presumably by forming a Gag 
binding site (Baig et al, 2008). 
The trans-acting regions for HIV-1 packaging have been mapped to the NC 
domain of Gag polyprotein, specifically to the Cis-His boxes, also called CCHC zinc 
fingers (CCHC = C-X2-C-X4-H-X4-C, where X= variable amino acids) within the NC 
domain. The critical role undertaken by these motifs suggests that a specific interaction 
between Gag and viral RNA takes place during the packaging of genomic RNA into 
virion particles (Aldovini & Young, 1990; D'Souza & Summers, 2005; Dorfman et al, 
1993). 
Since the 5’ side of pal (GGAG) has been found to be an essential element for 
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HIV-2 RNA packaging in vivo (Baig et al, 2008), we focused our attention on this region 
to study its interactions with Gag and NC. Here, we purified bacterially expressed HIV-2 
Gag and NC proteins and examined their binding to the 5’ side of pal by using wt and 
mutant RNA fragments corresponding to HIV-2 5’UTR. Using an EMSA 
(electrophoretic mobility shift assay), NC was found to bind to both wt and mutant HIV-2 
RNAs. However, Gag protein displayed a distinct preference for interaction with wt over 
mutant RNAs. These data suggest that NC interacts with low specificity with RNAs, 
while Gag can discriminate binding targets.  
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4.3. Materials and Methods 
 
4.3.1. Expression and purification of C-terminal 
His-tag NC fusion protein 
 
The open reading frame of NC with the inserted sequence for C-terminal His-tag 
(histidine-tag) was obtained by PCR amplification using modified pROD10 (a full-length 
plasmid containing infectious HIV-2 DNA sequence) (Lanchy & Lodmell, 2007) as a 
template, a sense primer containing an NdeI site (sNCNdeI; 5’-
TCCCATTCCATATGGCCCAGCAGAGAAAGGC-3’), and an anti-sense primer 
containing BamHI site and 6-His-tag (asNCBamHIS; 5’-AAGGATCCTAGTGAT 
GGTGATGGTGATGGGTCGTTGGGATATCGTAATCCTGAAAATACAGGTTTTAT
TCACCTGCCTGTCTATCTG-3’). The PCR product was gel purified and digested with 
BamHI/NdeI enzymes before ligation into the pET3a expression vector (Novagen), which 
was also digested with the same enzymes. The ligated product was transformed into 
BL21-Gold (DE3) pLysS competent cells (Stratagene). After transformation, several 
clones were picked for plasmid DNA purification and sequence analysis to confirm the 
presence of the NC-His-tag fusion insert.  
For protein expression, overnight cultures of the transformed BL21-Gold (DE3) 
pLysS cells were grown at 37°C in the presence of ampicillin and chloramphenicol. This 
was followed by 1:10 dilution next day with fresh LB in the presence of 0.2 mM ZnCl2. 
Cultures were grown at 37°C to an optical density of 0.6-0.7 at 600 nm. Finally the 
expression of the NC protein was initiated by the addition of 1 mM IPTG (isopropyl beta-
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D-thiogalactopyranoside), and continued for 5 hours. 
After expression, the cells were pelleted by centrifugation at 2700 rcf for 20 
minutes at 4°C, followed by lysis with Bugbuster protein extraction reagent (Novagen) in 
the presence of LysonaseTM Bioprocessing reagent (Novagen) and protease inhibitor 
cocktail (Sigma Aldrich), shaking for one hour at room temperature. The lysed product 
was spun at 15300 rcf for 30 minutes at 4°C in order to collect the soluble protein in the 
supernatant. The supernatant was mixed with the ProfinityTM IMAC-Ni-charged resin 
(BioRad) for purification of protein through the affinity of His-tag with the resin. After 
shaking for one hour at 4°C, the mixture was centrifuged for three minutes at 1000 rcf to 
remove the supernatant. The resin was washed for five times with wash buffer (50 mM 
NaH2PO4, 300 mM NaCl, 5 mM imidazole, 0.1 mM ZnCl2, pH 8.0), followed by the 
elution of protein using elution buffer (50 mM NaH2PO4, 300 mM NaCl, 500 mM 
imidazole, 0.1 mM ZnCl2, pH 8.0). Subsequently the NC protein was concentrated using 
centrifugal concentrators (Amicon Ultra: Ultracell 5K) and stored in storage buffer (25 
mM KCl, 25 mM K acetate, 0.1 mM beta-mercaptoethanol, 0.1 mM ZnCl2, pH 7.5) at 
4°C. The protein concentration was estimated by UV absorbance spectroscopy, using the 
extinction coefficient of 12 mM-1cm-1 and by SDS-PAGE (sodium dodecyl sulphate-
polyacrylamide gel electrophoresis). 
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4.3.2. Expression and purification of C-terminal 
His-tag Gag fusion protein 
 
The open reading frame of Gag with a C-terminal His-tag in the pET3a 
expression vector was obtained in two steps. In the first step, we introduced a His-tag in 
the mpROD10 plasmid at the C-terminus of Gag. This plasmid was called p333.3. 
Second, we used this plasmid as a template for the construction of Gag-expression vector. 
The p333.3 was built in the following steps: First, a PCR fragment was obtained from 
modified pROD10 (a full-length plasmid containing infectious HIV-2 DNA sequence) 
(Lanchy & Lodmell, 2007) using a sense primer (sXhoIHIS; 5’-
TTCTCGAGCATCATCACCATCACCATCAGGGGGAGACACC-3’) and an anti-sense 
primer (asROD2400; 5’-GGCTCTACTTTGGCGACTGG-3’). The amplified product 
was gel purified and digested with XhoI/BSU36I enzymes. This digested product was 
ligated into the mpROD10 vector, which was already digested with the same enzymes. 
After ligation, transformation, plasmid DNA purification, and the sequencing check, this 
plasmid (p333.3) was used as a template to produce a PCR product containing an open 
reading frame of Gag and a C-terminal His-tag. The PCR product was amplified using a 
sense primer (sGagNdeI; 5’-GATTGTGGCATATGGGCGCGAGAAACTCC-3’) and an 
anti-sense primer (asBcl2114; 5’-
TTTGAATGCTGTCGACTACTGGTCTTTTCCAAAGAGAG-3’) on p333.3 template. 
The amplified product was gel purified and digested with BclI/NdeI enzymes to ligate 
with BamHI/NdeI digested pet3a expression vector. The ligated product was transformed 
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in BL21-Gold (DE3) pLysS competent cells (Stratagene). From this, clones were selected 
for DNA purification and the sequences were verified to code for the Gag-His-tag fusion 
protein. 
Gag protein expression and purification were performed in the same way as NC 
protein expression and purification described above. After purification, Gag protein was 
concentrated using centrifugal concentrators (Amicon Ultra: Ultrcell 10K) and stored in 
the storage buffer (20 mM Tris, 500 mM NaCl, 0.1 mM ZnCl2, 10 mM beta-
mercaptoethanol, pH 7.5) at 4°C. The concentration of protein was estimated by UV 
absorbance spectroscopy, using an extinction coefficient of 73 mM-1cm-1 (sequence 
analysis program) and by SDS-PAGE. 
 
4.3.3. RNA synthesis 
 
The plasmid DNAs obtained from a previous study of in vivo SELEX (Baig et al, 
2008) were linearized with EcoRI before being transcribed into RNA.  Radiolabelled 
RNAs (1-561 nucleotides) from these EcoRI linearized templates were synthesized with 
the transcription kit (Ambion) in 20ul reaction containing T7 enzyme, 0.5 mM ATP, 0.5 
mM CTP, 0.5 mM GTP, 20 µCi of [32P] UTP (800Ci/mmol; Perkin Elmer) for 30 
minutes at 37°C, followed by digestion with RNase free DNase for 15 minutes at 37°C. 
After synthesis, RNA transcripts were purified by denaturing gel electrophoresis, were 
excised from the gel and were eluted in gel elution buffer (0.5 M (NH4)2 acetate, 0.2% 
SDS, 1 mM EDTA). 
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4.3.4. EMSA (electromobility shift assay) 
 
Radiolabeled RNAs (50,000 cpm/µl) were denatured in H2O at 90°C for two 
minutes then snap cooled on ice for two minutes. Increasing amounts of NC or Gag 
proteins (0 to 2µg for NC and 0 to 0.7µg for Gag) were added to a fixed amount of RNA. 
RNA-protein binding was allowed to proceed for 30 minutes at 37°C after adding the 
binding buffer (final concentrations: 50 mM Tris-HCl, pH 7.5 at 37°C, 40 mM KCl, 0.1 
mM MgCl2). Following incubation, samples were loaded with 2ul of 6X glycerol loading 
dye (40 % glycerol, 44 mM Tris-borate, pH 8.3, 0.25 % bromophenol blue) onto a 5% 
polyacrylamide gel. Electrophoresis was carried out for three hours at 87 V at 4°C in 44 
mM Tris-borate, pH 8.3 and 1 mM EDTA (0.5X TBE). Gels were autoradiographed after 
drying. 
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4.4. Results and Discussion 
 
To initiate in vitro binding studies, we recombinantly expressed two proteins of 
HIV-2, the Gag protein (p58) and, separately, the NC protein (p8), which is one of the 
domains of Gag protein in E.coli. Both proteins were expressed as fusion proteins with C-
terminal His-tag. These were then purified by using ProfinityTM IMAC-Ni-charged resin 
(BioRad) in a batch purification method according to the manufacturer’s protocol, 
described in Materials and Methods. Following purification, the proteins were analyzed 
by SDS-PAGE. Both proteins appeared on the gel corresponding to their expected size 
(Figure 21). 
 
                                          
Figure 21. SDS-PAGE analysis of C-terminal His-tag NC fusion protein. 
A. A bacterial pellet containing NC expressed protein was processed through lysis and then underwent 
batch purification as described in Materials and Methods. The purified protein was visualized by SDS-
PAGE followed by coomassie brilliant blue staining. Lanes 1 and 2 correspond to the ladder (marker) and 
the purified NC protein respectively. B. SDS-PAGE analysis of C-terminal His-tag Gag fusion protein: The 
Gag fusion protein was also purified in a similar manner similar to NC protein. Lanes 1 and 8 correspond to 
the ladder (marker) and the purified Gag protein respectively. The lanes 2 to 7 correspond to several 
washing steps. The molecular size of the marker proteins are indicated on left. Note: Due to tilted gel, 
proteins seem to migrate at different positions other than their size. 
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The 5’ side of pal (GGAG) was reported by our recent study, described in specific 
aim 2 as a critical element for HIV-2 genomic RNA packaging in vivo. We hypothesized 
that this sequence is a binding element for Gag protein during packaging in vivo. In order 
to study this hypothesis, here we used in vitro synthesized RNAs corresponding to 
5’UTR of HIV-2 RNA. We synthesized two radioactive RNAs, TTB-16 and TTB-78, 
which are sequences found and characterized for their effects on packaging in our in vivo 
SELEX study (Baig et al, 2008). In that study, it was shown that the GGAG sequence at 
the 5’ side of pal (as in TTB-78; wt) is important for efficient genomic RNA packaging, 
and that the ACCT in the same location (as in TTB-16) causes defective packaging of 
genomic RNA.  
After purification of proteins and radiolabelled RNAs, the in vitro binding studies 
were performed using an EMSA. Initially, the NC protein alone was used to test its 
binding with wt RNA. Interestingly, we found two discrete bands for wt RNA on the gel 
in the absence of protein (Figure 22; lane 1). Since alternative conformations, as a result 
of long distance interactions, have been proposed for the HIV-2 leader RNA (Dirac et al, 
2002a; Lanchy et al, 2003a; Lanchy et al, 2003b), it was surprising for us to see two 
distinct monomer bands for HIV-2 RNA on a native gel. We termed these lower and 
upper species as fast and slow migrating conformers, respectively. Berkhout and 
coworkers have shown that HIV-1 RNA also adopts two different monomeric 
conformations that migrate differently on gels (Huthoff & Berkhout, 2001). Secondary 
structural analysis of these species suggested that the fast migrating conformer can form a 
rod like structure due to LDI and that the slow migrating conformer was proposed to 
contain BMH structures (Huthoff & Berkhout, 2001).  
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It is known that HIV-1 NC has non-specific nucleic acid chaperone activity, 
which is accelerated by its binding to misfolded structures of nucleic acids and allowing 
them to rearrange (Cruceanu et al, 2006; Levin et al, 2005). Although HIV-1 NC 
protein’s chaperone activity for converting the LDI conformer to a BMH conformer has 
been the subject of study (Huthoff & Berkhout, 2001), little is known about the 
chaperone activity of HIV-2 NC in this regard. We report in this study that HIV-2 NC 
also behaves as chaperone to convert one conformer of HIV-2 leader RNA into another. 
As seen in Figure 22, the fast migrating conformer was converted to the slow migrating 
conformer with increasing concentrations of NC. Interestingly, with the increasing 
concentrations of NC, the migration of the upper band was retarded, suggesting the 
formation of an RNA-protein complex (Figure 22). 
          
Figure 22. EMSA for NC- wt RNA interactions.  
The radiolabelled wt HIV-2 leader RNA with GGAG sequence at the 5’ side of pal at 50,000 cpm/µl/each 
lane was incubated with increasing concentrations of NC-fusion protein  (0, 0.002, 0.0025, 0.0033, 0.005, 
0.01, 0.02 and 2, each at µg/10ul reaction) for 30 minutes in the presence of binding buffer and loaded on 
native PAGE. The two conformers of monomeric RNA are represented by filled asterisk (fast conformer) 
and empty asterisk (slow conformer). Arrows indicate the retarded RNA-protein complexes. 
 
In order to see whether non-GGAG pal sequences can also bind to NC in vitro, we 
used TTB-16, which harbors the packaging defective AACT sequence in pal. 
µg/10µl 
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Surprisingly, we could not see a distinctive mode of NC binding with this RNA as 
compared to the GGAG wt RNA (compare Figure 23 to Figure 22). Since it has been 
reported previously that HIV-1 NC protein can bind non-specifically with RNAs in vitro  
(Berkowitz et al, 1993; Clever et al, 1995), the similar pattern of binding observed here 
for wt and mutant RNAs suggests that the binding of HIV-2 NC for RNA is non-specific. 
In the future, this notion could be analyzed further with the use of competitor RNAs, used 
in binding studies of HIV-1 NC and those RNAs used in this study to reduce the 
background of non-specific interactions (Clever et al, 1995). 
      
Figure 23. EMSA for NC-mutant RNA interactions.  
The radiolabelled mutant RNA with ACCT sequence at the 5’side of pal at 50,000 cpm/µl/each lane was 
incubated with increasing concentrations of NC-fusion protein  (0, 0.002, 0.0025, 0.0033, 0.005, 0.01, 0.02 
and 2, each at µg/10ul reaction) for 30 minutes in the presence of binding buffer and loaded on native 
PAGE. The two conformers of monomeric RNA are represented by filled asterisk (fast conformer) and 
empty asterisk (slow conformer). Arrows indicate the retarded RNA-protein complexes. 
 
It has been demonstrated that specific interactions between viral genomes and 
Gag take place via the NC domain within Gag in HIV-1 (Berkowitz et al, 1995b; Zhang 
& Barklis, 1995). Therefore, we tested to see whether a differential pattern of interaction 
could be seen between wt and mutant RNAs in the presence of Gag protein. As seen in 
Figure 24, both RNAs showed similar migration patterns with the appearance of two 
µg/10µl 
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bands in either absence or presence of low concentration of Gag. However, as the 
concentration of Gag was increased, the fast migrating band for wt disappeared as 
compared to TTB-16, which still had two distinct bands at this concentration of Gag 
(Figure 24; compare panel A with panel B). These results demonstrate that HIV-2 Gag 
protein also possesses the chaperone activity as seen for HIV-1 Gag (Cruceanu et al, 
2006). Furthermore, it displays the specificity of interaction of Gag for wt RNA as 
compared to mutant RNA. These results correlate with our in vivo results, where GGAG 
was determined to be essential for HIV-2 genomic RNA packaging and ACCT was a 
determinant of packaging defects (Baig et al, 2008). 
                  
Figure 24. EMSA for Gag-RNA interactions.  
The radiolabelled RNAs (wt RNA; TTB-78, Figure 24A and mutant RNA; TTB-16, Figure 24B) at 50,000 
cpm/µl were incubated with increasing concentrations of Gag-fusion protein  (0, 0.007 and 0.07, each at 
µg/10ul reaction) for 30 minutes in the presence of binding buffer and loaded on native PAGE. Two 
conformers of monomeric RNA are represented by filled asterisk (fast conformer) and empty asterisk (slow 
conformer).  
 
Our results also corroborate the proposed folding patterns of the pal-SL1 region, 
which differ between wt and TTB-16 RNAs. In wt RNA, the predicted secondary 
structure for the pal-SL1 region showed an extended SL1 structure, where the 3’ side of 
pal is bound with a sequence downstream of SL1 and the 5’ side of pal is exposed and 
µg/10µl 
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present as an unpaired region. In this model, the GGAG sequence was proposed to be a 
binding target for the Gag binding (Baig et al, 2008) (Figure 25A). In contrast, 5’ pal of 
packaging defective TTB-16 is entrapped by another sequence downstream of extended 
SL1, which was proposed to be an inappropriate presentation for Gag binding (Baig et al, 
2008) (Figure 25B). We interpret the present in vitro Gag-RNA binding results to mean 
that the extended SL1 structure with an exposed 5’ pal can bind with Gag to promote 
packaging, while the presence of a non-GGAG sequence at the 5’ side of pal is either not 
recognized by Gag or is sequestered by aberrant base-pairing and can not be accessed by 
Gag.  
 
      
 
 
 
 
Figure 25. Predicted secondary structures of TTB-78 (wt) and TTB-16 RNAs. 
A. Secondary structure model of pal-SL1 domain in HIV-2 ROD isolate (GenBank accession number 
M15390 (Baig et al, 2007; Lanchy & Lodmell, 2007)) and non-selected RNA from in vivo SELEX study as 
predicted by Mfold (Zuker, 2003). Stem B represents the interaction between 5’-GCUCC of pal and 
GGAGC-3’ sequence just downstream of SL1. B. The GGAG sequence at 3’ end of stem B in TTB-16 is 
sequestered by base pairing with pyrimidines at the 5’ end of pal and potentially makes stem B significantly 
more stable. The nts different from the wt sequence are shown with lowercase letters. 
The stem B structure was predicted using two-state hybridization model in the DINAMelt server 
(http://www.bioinfo.rpi.edu/applications/hybrid/twostate.php) using standard parameters (RNA at 370C, 
[Na+]= 1M, [Mg2+]= 0M and [strand]= 0.00001M (Markham & Zuker, 2005).  
  
 
 
 
TTB-78 
B A 
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Chapter 5: Conclusions and Future 
Directions 
 
5.1. Conclusions 
 
The main intent of the research presented in this dissertation was to understand 
the regulation of the dimerization and packaging processes of HIV-2 RNA. The research 
emphasized a 10-nt palindrome sequence located in the leader region of HIV-2 RNA. 
Through randomization of this sequence within HIV-2 leader and full-length RNAs, 
followed by in vitro and in vivo selections, we demonstrated that pal is a critical element 
for the regulation of dimerization and packaging. Biochemical characterization supported 
the existence of essential RNA structures, and phenotypic characterization of mutant 
viruses showed the physiological significance of these structures and signals.  
Both the in vitro and the in vivo selections identified an extended SL1 structure in 
which 3’ pal is entrapped in a stem and 5’ pal is exposed. This structure was discovered 
to be important for HIV-2 leader RNA dimerization in vitro and for genomic RNA 
packaging in vivo. The extended SL1 was also identified as a recognition element for 
Gag-RNA interactions in vitro.  
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5.2. Future Directions 
 
Studies on the pal region of packaging signal provide evidence that it plays an 
important role in the packaging and viral replication of HIV-2. The findings presented in 
this dissertation provide additional support about the role of pal in packaging. However, 
the underlying mechanism of packaging is not resolved completely at the moment. 
Because packaging is an important step during viral replication, it may represent a new 
antiretroviral targets for anti-HIV therapy. Some suggestions and routes are presented 
below. 
 
1. To further understand whether the extended SL1 structure, along with the 
exposed 5’ pal, is the principal recognition element for Gag, a logical extension of the 
results presented here would be to search for Gag-binding RNA aptamers. RNA aptamers 
for HIV-1 Gag protein have been isolated using in vitro SELEX, in which short stretches 
of randomized nucleotides favored a single structural motif after several rounds of 
selection (Lochrie et al, 1997). Similar methods could be employed to select consensus 
secondary structures for the HIV-2 Gag.  
After the generation and characterization of the aptamer, the sequence could be 
used to replace the pal-SL1 region of HIV-2 RNA in mutant viruses. Determination of 
the packaging phenotype would shed light on whether Gag recognition of RNA is 
sufficient to promote packaging. 
2. The small RNA aptamers developed above could potentially also block viral 
replication (Joshi & Prasad, 2002). The Gag protein is critical for several steps of viral 
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replication including packaging and assembly (Kaye & Lever, 1999; Kim & Jeong, 2004; 
Luo et al, 1994). The results of our specific aim 3 also provide evidence that Gag can 
bind with HIV-2 RNA specifically, and can therefore facilitate the packaging of HIV-2 
genomic RNA in vivo. This suggests that Gag protein could be a useful target for the 
inhibition of viral replication by the use of aptamers. 
To explore this aspect, first an in vitro competition binding experiment would be 
carried out using Gag protein and aptamers versus HIV-2 leader RNA. If the aptamers 
successfully compete with wt leader RNA sequence for Gag binding in vitro, we shall 
test the inhibitory effect of these aptamers on genomic RNA packaging in vivo by using a 
method similar to that employed by Jeong’s group (Kim & Jeong, 2004). If the high 
affinity aptamers can be efficiently expressed in HIV-2 infected cells, we would predict 
to see a packaging defect along with reduced viral replication. This study would be a 
good start towards the development of an inhibitor of Gag protein, which may ultimately 
lead to anti-HIV therapeutic strategies in the future. 
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